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The Effects of Signal Control, Gender, and Self-Efficacy on Perceived Control, Signal 
Utility, and Biofeedback-Mediated Relaxation Levels (98 pp.)
EMG-biofeedback (EMG-BF) relaxation therapy has been challenged as more 
expensive and no more clinically effective than other relaxation methods. Proponents 
acknowledge that other techniques may be effective but argue that EMG-BF is a 
valuable tool in their therapeutic repertoire. Research indicates that benefits of BF 
reflect cognitive changes rather than direct effects of somatic changes via lowered 
EMG. Control and mastery expectations may be related to relaxation success. Studies 
suggest that actual and perceived control over the intensity of aversive stimuli 
increases tolerance of aversive stimuli, but instrument control in non-aversive 
situations has not been well studied. This study examined the effects of providing; Ss 
with control over the EMG signal.
In a 3 x 2 between-within blocked design, male and female university students (N = 
144) assessed as high or low in self-efficacy for self-regulation (SESR) were assigned 
to one of three BF conditions (control over the presence or absence of the signal, 
intermittent signal, continuous signal). Repeated-measures ANOVAs were conducted 
on the dependent variables (EMG and subjective relaxation, SESR, efficacy 
expectations, and perceived control) with pre-test SESR, gender, and feedback 
condition as independent variables. A two-way ANOVA was conducted on post-test 
perceived signal utility. It was hypothesized that Ss in the high SESR/signal-control 
condition would experience the highest relaxation levels, perceived signal utility, and 
perceived control.
Significant differences were found for subjective relaxation and perceived utility,, 
with signal-control Ss reporting both the highest levels of relaxation and appreciation 
for the utility of the EMG signal. No main effect of condition on EMG was found 
although, as a group, Ss significantly lowered their EMGs from pre to post.
Interactions were noted involving gender and confidence, with female Ss and less 
confident Ss making greater gains in SESR and perceived signal utility than males and 
high confidence Ss. Males’ perceived control was highest in the signal-control group 
and lowest in the intermittent-signal group, whereas females exhibited an opposite 
pattern. Cultural explanations are offered for this gender-specific reaction to an 
experimenter-controlled signal.
Director: Balfour Jeffrey, Ph.D.
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Chapter 1 - Introduction
The Effects of Signal Control, Gender, and Self-Efficacy on Perceived Control, Signal 
Utility, and Biofeedback-Mediated Relaxation Levels
The recent focus on the influence of cognitive and personality variables on the 
efficacy of EMG biofeedback-mediated relaxation (EMG-BF) therapies may give rise 
to therapy designs that account for those cognitive and personality factors that enhance 
or inhibit the efficacy of EMG-BF relaxation training. Although the uneven results of 
studies examining the efficacy of EMG-BF relaxation training have raised doubts 
about the future of such therapy, some within the biofeedback field (Hatch & Saito, 
1990; Middaugh, 1990; Peper & Sandler, 1987; Qualls and Sheehan, 1984) have 
argued against the trend among many researchers (Johnston, 1991; Roberts, 1985; 
Simkins, 1982) to denigrate all biofeedback relaxation work. They caution that the 
studies that suggest that the EMG method of relaxation is no more clinically effective, 
and less cost effective, than other relaxation methods are best characterized as 
methodologically inconsistent, when examined as a group (Gatchel, 1982), and 
individually flawed by the failure of most researchers to attend to the specific effects 
of cognitive variables on EMG-mediated relaxation. Other prominent researchers 
concur that it would be premature to dismiss any of the current applications of 
biofeedback as ineffective (Hatch, 1987a; Middaugh, 1990) and cite as more pertinent 
than the general question "Does biofeedback work?" are the questions of what 
biofeedback actually contributes to the therapeutic process, with which types of 
patients, and when carried out in what way.
1
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Biofeedback researchers’ concern about the decline of their field is warranted. 
Hatch and Saito (1990), in tallying the number of biofeedback-related journal articles 
and doctoral dissertations published in each year from 1970 to 1987 have noted a 21% 
decline (when compared with the previous four years) in publications between 1984 
and 1987. While there is a growing reluctance in academia to support an area that has 
taken on some stigmatization as a pseudoscience, Hatch and Saito suggest that the 
biofeedback field may have also reached a period of maturity in which many of the 
easier questions have been studied and that the declining interest may be, in part, 
related to the fact that many of the questions that remain require more time and effort 
to investigate. Cognitive variables and their influence on biofeedback effectiveness are 
cited as one complicated area that needs increased attention.
This review will first briefly cover the history of EMG biofeedback relaxation 
therapy, how EMG biofeedback is thought to work physiologically, conflicting views 
on the generalizability of EMG mediated relaxation of the frontales muscles to 
systemic reduction of muscle tension, and a discussion of the rational for continuing to 
use biofeedback as both a clinical and a research tool. Following this discussion, two 
cognitive variables, self-efficacy and perceived control, that may influence biofeedback 
outcomes, will be discussed and operationally defined. Finally, a review of the 
research supporting the role of self-efficacy and perceived control in influencing 
specific task outcomes will lead to a statement of the purpose and hypothesis of this 
study.
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EMG Biofeedback Relaxation Therapy: A Brief History
The term biofeedback generally refers to a group of clinical procedures in 
which an external sensor is used to provide a person with information about the state 
of a bodily process, usually in the effort to effect some quantifiable change in that 
state. Although a number of different biofeedback techniques have been applied as 
therapy for a wide variety of physical complaints, this discussion will be primarily 
limited to the use of electromyographic biofeedback (EMG-BF) as an aid in muscle 
tension relaxation.
Current biofeedback techniques may be traced to animal experiments (Miller, 
1969) that led researchers to recognize that the "involuntary" responses mediated by 
the autonomic nervous system were subject to operant conditioning. Miller’s 
instrumental learning paradigm, when coupled with the cybernetic and systems 
analysis paradigms, gave rise to vigorous efforts to use an external signal linked to a 
physiological state for therapeutic improvements in a variety of physical maladies. In 
addition, biofeedback was heralded as a useful scientific tool as a means of achieving 
experimental manipulation over specific physiological processes so that the 
relationship of one process to another and to specific environmental and behavioral 
conditions might be explored (Schwartz & Beatty, 1977). Current clinical uses of 
biofeedback for which clinical efficacy has been demonstrated include treatment of 
tension headache (Andrasik, 1989; Labbe & Ward, 1990) and low back pain 
(Andrasik, 1989), migraine headache (Blanchard, Andrasik, Ahles, Teders, & O’Keefe, 
1980; Richter, McGrath, & Humphreys, 1986; Sargent, Solbach, Coyne, Spohn, &
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Segerson, 1986), essential hypertension (Blanchard, 1990), temperomandibular 
disorders (Mealiea & McGlynn, 1987), and neuromuscular re-education after a stroke 
or other injury (Wolf & Fischer-Williams, 1987).
The use of EMG-BF as a relaxation therapy grew out of efforts to determine of 
what use biofeedback was, physiologically. It was quickly recognized that providing a 
person with information about his or her efforts to relax seemed to facilitate muscle 
relaxation (Budzynski & Stoyva, 1969). As biofeedback equipment and training 
procedures improved, researchers began, increasingly, to combine biofeedback training 
techniques with relaxation techniques to facilitate biofeedback training. When 
encouraging results ensued, the next logical step was to combine biofeedback training 
procedures with relaxation techniques such as Jacobsonian progressive relaxation 
(Jacobson, 1938) for the purpose of providing psychophysiological treatment for 
specific "psychosomatic" disorders such as chronic tension, tension headache, and 
migraines. In the biofeedback literature, tension is commonly defined as an excessive, 
chronic, or somehow maladaptive level of tonus in all or some of the skeletal muscles 
(Schwartz & Beatty, 1977). In attempting to influence these problems with relaxation 
therapy, alone, a problem had been the inability of researchers to be sure that 
relaxation techniques were actually-being learned and that the patient was not merely 
reporting relaxation when high levels of tension were still present. Budzynski and 
Stoyva (1973) reasoned that accurate detection of the level of muscle tension, coupled 
with the feedback of this information to the subject, would provide the means for 
overcoming these difficulties. Thus feedback was provided for both researcher and
5
patient. A major expectation was that the feedback signal would enable patients to 
obtain a state of muscle relaxation more quickly and more thoroughly than had been 
possible with relaxation techniques alone. Among the additional original assumptions 
(Budzynski & Stoyva, 1973), currently under attack for lack of empirical 
substantiation, were that muscle relaxation in a specific site would generalize to 
relaxation in other muscles, that a generalized relaxation of muscles would produce a 
"cultivated low arousal" that would compete against sympathetic nervous system 
(SNS) arousal, and that the reduction in SNS activity would have observable benefits 
to the patient. Reviews of the literature in the early 1980s (Burish, 1981; Holmes, 
1981; Simkins, 1982) yielded little evidence that relaxation generalizes much beyond 
the target muscle nor that lasting reduction of autonomic arousal is the usual result of 
EMG-BF relaxation therapy.
Since the initial decade of uncritical enthusiasm that surrounded biofeedback, 
the claims from within the biofeedback field for the efficacy of EMG feedback as 
relaxation aid have become more modest, if not apologetic (Frank, 1982; Middaugh, 
1990; Peper & Sandler, 1987). Yielding equivocal results, a number of studies have 
compared the degree of muscle relaxation achieved using EMG-BF with that obtained 
using other relaxation techniques such as Jacobsonian progressive relaxation and 
imagery-mediated relaxation. More than twenty years ago, Cleaves (1971) found 
EMG-BF equal but not superior to progressive relaxation (PR) as a relaxation 
technique. Other researchers also began reporting equivalent relaxation results 
between EMG-BF and other techniques in both normal subjects (Haynes, Mosely, &
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McGowan, 1975; Fee & Girdano, 1978) and those with tension headache (Cox,
Freundlich, and Meyer, 1975; Haynes et al., 1975) or anxiety complaints (Sime &
DeGood, 1977). Additionally, a study by Alexander (1975) suggested the superiority
of EMG-BF in attaining lowered EMG levels but indicated no generalization of
relaxation to other muscle groups and no difference in subjective reports of relaxation.
In reviewing this study, however, Tarler-Benlolo (1978) noted that the subjects had
unusually low initial EMG levels that may have contributed to the failure to find a
generalization effect and that the validity of the procedure for assessing subjective
relaxation was doubtful. During the same period, other outcome studies suggested the
superiority of EMG-BF over other relaxation techniques (Canter, Kondo, & Knott,
1975; Coursey, 1975; Reinking & Kohl, 1975). More recently, a comparison study of
EMG-BF, progressive relaxation (PR), and EMG-BF combined with PR found
equivalent efficacy of EMG-BF and PR but superior efficacy for EMG-BF and PR
combined (See & Czerlinsky, 1990).
Given the inconclusive results of twenty years of efforts to find differential
efficacy between EMG-BF and other relaxation techniques, Roberts (1985), in a harsh
assessment of the current state of biofeedback research and clinical applications,
elevates the criticism of the field beyond that of other researchers’ (Andrasik &
Holroyd, 1983; Middaugh, 1990; Reed, Katkin, & Goldband, 1986) in saying that,
...there is little evidence that biofeedback is the essential ingredient in 
the therapeutic effects that are attributed to it.
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Roberts goes on to deplore the popularity of biofeedback as a tool in the
armamentarium of the behavioral medical technician. Curiously, however, he points
out that he does not,
...know of a single clinician who is successfully using biofeedback, 
myself included, who does not use it as part of a multimodal package 
that may include such techniques as relaxation training, life-style 
management, counseling, and so on. In my own program, it appears 
that the more modes we use, the more successful we tend to be.
Admittedly, biofeedback is often the centerpiece of this smorgasbord of 
offerings, but that does not mean it is the most critical one.
Roberts’ rejection of biofeedback as the "essential or specific technique for the
treatment of any condition" is thus followed by a qualified endorsement of
biofeedback as a frequent centerpiece of his own therapy program.
Roberts’ attack on biofeedback practitioners and researchers seems directed,
primarily, at what is rapidly becoming a straw-person. In a review of both laboratory
and clinical studies it is increasingly difficult to find recent articles by biofeedback
researchers in which claims for the efficacy of biofeedback as a relaxation tool extend
much beyond the scientific support offered in the literature. Additionally, most
practitioners seem to have abandoned the singular use of biofeedback, in favor of the
sort of multimodal approach described by Roberts (Hatch, 1990b; See & Czerlinsky,
1990).
In the face of contradictory evidence for the efficacy of EMG-BF over other 
relaxation methods a number of rationales and explanations have arisen in defending 
the continued use of biofeedback for learning relaxation. Stoyva (1983) argues that a 
primary benefit of biofeedback is that information about the progress at reducing
muscle tension is immediately and directly available to its users and that such 
information may be especially encouraging to patients who, without feedback, may be 
cognitively unaware of their progress. Stoyva cites this as an influential factor in a 
dropout rate of less than 10% in his EMG-BF relaxation-mediated headache 
treatments.
A number of researchers have suggested that social psychological factors 
inherent in the biofeedback context (independent of actual performance at the operant 
modification of physiological processes) may serve as a potent "placebo" that is 
effective in inducing experiential and behavioral changes by evoking the EMG-BF 
trainee’s latent self-control abilities. Indeed, the studies that have demonstrated the 
superiority of biofeedback over other relaxation techniques have been regularly 
criticized for obtaining their differential results via placebo effects (Frank, 1982; 
Furedy & Shulhan, 1987; Stroebel & Glueck, 1973).
As defined by Critelli (1985), "placebos are treatments whose effectiveness is 
believed to derive solely from common factors." In attributing the efficacy of 
biofeedback to a pure placebo effect any beneficial effects specific to the biofeedback 
are ruled out and common factors such the clinician/patient relationship, a healing 
setting, a plausible healing rationale, and/or expectancy for cure usually are invoked 
(Frank, 1982; Critelli, 1985). In highlighting the need for credible attention-placebo 
control procedures after their study of differential efficacy of contingent vs non­
contingent vs false-feedback, Burnette and Adams (1987) caution that even slight 
suspicions among subjects about the credibility of control procedures may lead to
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results that, due to a failure to provide an adequate attention placebo, suggest specific 
factors at work. Henry (1985) suggests that common factors and specific factors are 
interwoven, interactive, and are likely inseparable and that efforts may be best spent 
on increasing the therapeutic effectiveness of a given technique, regardless of whether 
it operates through common or specific mechanisms. Gatchel (1982) notes that if a 
placebo factor(s) is isolated as the major active ingredient in biofeedback treatment, 
the finding would not obviate its therapeutic effectiveness so long as the "clinician 
recognizes this so that the best treatment for a particular patient may be implemented". 
Should EMG-BF eventually emerge as a treatment package clearly superior to, say, 
progressive relaxation, we may still be able to draw only limited conclusions about the 
specific role of the BF in determining that superiority. Since non-specific effects of 
the two packages may differ in many respects, there are numerous competing 
explanations for the observed differences. Among the possibilities to consider in 
attempting to explain a differential effect are that biofeedback provides information 
about a physical process that the PR group was denied, that the two procedures require 
attention to external/objective vs internal/subjective signals respectively, and that the 
Zeitgeist of the electronic age and current love of gadgetry gives biofeedback more 
credibility in the public mind. Hatch (1982) notes that another eventuality may be 
equivalent efficacy of EMG-BF and PR but that the similar outcomes are produced via 
different pathways.
Several researchers within the biofeedback field caution that neither beneficent 
naivete nor personal confidence in the efficacy of EMG-BF will endear the field to
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other health care professions or to third party payors and that poor methodologies, 
particularly in the area of attention-placebo control groups will eventually doom the 
field (Furedy & Shulhan, 1987; Hatch, 1982; Simkins, 1982).
Holroyd & Penzien (1984) have originated a model that borrows from and 
expands the placebo theory. They postulate a change mechanism by which the impact 
of performance accomplishments on cognitive processes is thought to mediate 
symptom improvement. More specifically, they believe that when patients perceive 
the biofeedback experience as a credible measure of success in controlling a physical 
state, and subsequently experience success in controlling that state (whether or not the 
success is real or contrived by the experimenter), they will view their symptoms as 
having an internal locus of control and will view themselves as more self-efficacious 
in influencing their symptoms. These cognitive changes are thought to lead to more 
persistent efforts to control symptoms.
This project borrows heavily from this model of self-healing in which 
awareness of ability to control a physical state is of as much, or more, therapeutic 
benefit than is actually controlling that state. The general question of whether 
biofeedback works, or works primarily as a placebo, is not the question of interest. 
What is of interest is in what form and manner biofeedback should be offered in order 
to most powerfully influence the patient in a therapeutic manner and how research 
should proceed in order to illuminate those cognitive variables that have a meaningful 
therapeutic impact.
Cognitive Influences on Biofeedback Relaxation Efficacy
As was noted in the preceding review of the history and theories about 
biofeedback relaxation, biofeedback as a treatment was originally based on a strictly 
biophysical concept centered on the conditioned control of peripheral neuromuscular or 
neurochemical processes (Budzynski & Stoyva, 1969; Anchor, Beck, Sieviking, & 
Adkins, 1982). That autonomic nervous system reactions, traditionally viewed as 
outside the realm of voluntary control, were at least partly susceptible to voluntary 
control (Miller, 1969, 1973, 1978) had been a surprising discovery. The emphasis had 
previously been on peripheral rather than central systems. Electromyographic 
feedback’s efficacy in reducing a patient’s feelings of tension, or in reducing the 
frequency and severity of tension headache was attributed to the control of local 
muscle tension (usually in the frontales muscles of the forehead or the cervical 
muscles of the dorsal neck) rather than to higher-order nervous system activity such as 
that involved in cognitive appraisals of self-efficacy in controlling tension levels. 
Lazarus (1974) was among the first to argue that the most important factor in 
therapeutic relationships is how the person construes his/her situation and that such 
appraisal and expectations for successful coping are dependent on higher forms of 
brain activity. The feedback procedure is thus regarded as an event that precipitates 
certain adaptationally important processes involving appraisal and coping that change 
the likelihood and/or potency of the stress symptoms. Findings in a landmark series 
of studies of cognitive influences on tension headache sufferers have given strong 
support to this view (Andrasik & Holroyd, 1980, 1983; Holroyd & Penzien, 1984). In
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an altered biofeedback contingency study the researchers found that improvements in 
tension headache activity were unrelated to actual success at lowering or raising EMG 
levels but were related to patients’ perception of success at lowering EMG levels. 
Successful treatment of tension headache sufferers using EMG biofeedback techniques 
seems to depend on judgements of self-efficacy in controlling somatic processes rather 
than on actual somatic effects of reduced muscle tension. These findings suggest that 
central neural processes are of primary importance in mediating the positive effects of 
biofeedback treatment.
Among those cognitive variables that bear scrutiny for their usefulness in 
predicting responsiveness to EMG-BF are self-efficacy expectations and perceived 
control. These two constructs are of special importance in considering cognitive 
influences on EMG-BF efficacy because, unlike global or dispositional constructs like 
locus-of-control, perceptions of self-efficacy and of control are situationally specific. 
The terms self-efficacy expectations and perceived control refer to cognitive constructs 
that may have an effect on the EMG-BF trainee’s subjective sense of relaxation and, 
perhaps, his/her objective (EMG level) depth of relaxation as well.
Self-efficacy refers to one’s confidence in his or her ability to behave in such 
a way as to produce a desirable outcome (Bandura, 1977). Perceived control refers to 
the belief that one has at one’s disposal a response, or an array of resources, that can 
influence the outcome of an event (Thompson, 1981). Thus the term self-efficacy 
expectation describes a certain level of confidence in one’s ability to effect a particular 
response, if available, whereas perceived control refers to the perception of the
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availability of that response. Perceived control cognitions and self-efficacy 
expectations can be exemplified by a group of people who have been asked to retrieve 
data from a computer. The computer keyboard may be recognized by each person as 
an adequate tool for retrieving data, and thus may be regarded as a potentially useful 
resource, but individual levels of confidence in ability to effectively operate the 
keyboard may vary considerably.
Self-Efficacy and Self-Efficacy Expectations
In Bandura’s (1977) conceptualization of self-efficacy, cognitive processes play 
a central role in learning new skills and in changing most behavior problems. The 
general process of reinforcement affects behavior by creating the awareness that 
specific actions will produce expected rewards or stave off negative events. Thus 
reinforcement works not as an automatic response strengthener but as a motivating 
mechanism. "Both the anticipated rewards of success and the negative appraisals of 
insufficient performances provide motivation for action" (Bandura, 1977). Out of this 
theoretical framework arises the concept of self-efficacy as the expectation that one 
can perform the actions required to produce some outcome that is satisfactory to 
oneself. Self-efficacy may be further explained as an awareness of personal mastery.
Self-efficacy theory contrasts with formulations such as locus of control 
(Rotter, 1966) and learned helplessness (Abramson, Seligman, & Teasdale, 1978) that 
postulate that people develop general, pervasive, and consistent differences in their 
belief in their ability to cope across a wide variety of situations, and that this 
generalized belief influences the way in which they choose to behave. Self-efficacy
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theory (Bandura, 1977, 1982, 1989), on the other hand, argues that people have higjily 
specific expectations about their ability to perform highly specific behaviors, rather 
than overall response tendencies. Self-efficacy theory specifies that people have 
"efficacy expectations" about their ability to perform specific behaviors, and that it is 
the level and strength of efficacy for that behavior that determines whether or it will 
be attempted, how much persistence will be shown, and what the final result will be. 
Efficacy expectations arise from previous experience, from observation, from verbal 
inputs, and from emotional states, and are seen as determinants of behavior (Bandura,, 
1977). Behavior change programs, therefore, are effective to the extent that they alter 
efficacy expectations.
Bandura distinguishes self-efficacy theory from other cognitive theories relating 
to expectancies. Bandura is concerned with the person’s belief in his or her ability to 
produce particular responses, while other theories, he argues, are concerned with the 
effectiveness of those responses. These beliefs, "efficacy expectations" and "outcome 
expectations," are sharply distinguished by Bandura (1977). Efficacy expectations are 
defined as "the conviction that one can produce the behavior required to produce 
certain outcomes", and outcome expectations are defined as "a person’s estimate that a 
given behavior will lead to certain outcomes" (Bandura, 1977). Thus, outcome
i
expectations are seen as independent of the individual’s belief in his or her 
capabilities.
It has been argued that outcome expectations should not be ignored by self- 
efficacy theory. Teasdale (1978) has questioned the practical distinction between
15
efficacy and outcome expectations, noting that one cannot have efficacy expectations 
concerning a particular goal without also having outcome expectations regarding the 
perceived effectiveness of the behaviors involved. It seems clear that there is a logical 
distinction between the two concepts, but he argues that it may be impossible to 
distinguish the two empirically. Kazdin (1978) suggested that outcome expectations 
alone may predict behavior without the need to postulate efficacy expectations. He 
argues that persistence and effort may be explained by reference to what a person 
believes will be the outcome of an action, regardless of whether he or she is capable 
of performing it. He also questions whether it is possible to assess efficacy without 
confounding it with outcome expectations, known skill level, and incentives.
Bandura’s (1978) reply was that it is (italics added) possible to distinguish 
empirically between the two with reference to their effects. When efficacy 
expectations are low, a low outcome expectation will be accompanied by a withdrawal 
from the situation and a high outcome expectation is unlikely to be acted upon. If 
efficacy is high, low outcome expectations will be associated with intensification and 
variation of effort, and high outcome expectations with successful performance. 
Outcome expectancy and self-efficacy expectations must be differentiated because 
"while a person can believe that certain actions will produce a particular outcome, if 
he or she is doubtful about his or her own ability to perform those actions the 
information does not influence them to initiate such actions" (Bandura, 1977).
Efficacy is a more important determinant, because the way in which a person 
interprets and reacts to outcome expectations is determined by efficacy. Regarding
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assessment, Bandura (1982) points out that it is the researcher’s responsibility to 
establish conditions under which accurate response is most likely and to ensure that 
questions are understood.
Perceived Control and the Role of Appraisal
The terms outcome expectation and perceived control are sometimes used 
almost interchangeably (Thompson, 1981) but are used in this study to describe 
constructs that differ substantially in their operational definitions. Whereas outcome 
expectancy generally refers to one’s estimate that a given behavior will likely produce 
a given outcome, perceived control will be defined, in agreement with Litt (1988) as 
the appraisal of the total array of resources available, including relevant skills, 
techniques, and tools, in influencing the impact of an impending event. This definition 
is broad enough to include both aversive events and those events that might better be 
characterized as challenging. A number of investigators have attempted to derive 
typologies of control. Averill’s (1973) typologies have frequently been used. He 
specifies three types of control; behavioral control, the availability of a response that 
can directly modify the physical characteristics of an aversive event; cognitive control, 
the processing of information so as to make an aversive event less stressful; and 
decisional control, the opportunity to choose among multiple courses of action. Other 
typologies are Miller’s (1979) instrumental, self-administration, actual control equated 
for predictability, and potential control; and Thompson’s (1981) behavioral, cognitive 
(belief in a cognitive strategy that can influence the aversiveness of an event), 
informational control, and retrospective control. Although each of these distinctions
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may have some heuristic value in their specific context, they may be of little direct 
value in the study under consideration because, as Litt (1988) notes, many of the types 
of control are difficult to separate from one another. In behavioral control, for 
instance, we might expect that the behavior may produce cognitions about ability to 
control an event, thus possibly invoking cognitive control as well. In general, it 
appears that perceptions of cognitive control and those of behavioral control have 
analogous influence on the impact of stressful events. Subjects who were led to 
believe that they had more behavioral control, for instance, have been able to tolerate 
more intense electrical shock (Bowers, 1968; Staub, Tursky, & Schwartz, 1971), more 
cold-pressor pain (Kanfer & Seidner, 1973; Litt, 1988), and more loud noise (Corah & 
Boffa, 1970; Glass, Singer, & Friedman, 1969). Similarly, availability of a cognitive 
strategy has also been found to increase tolerance and threshold of pain (Kanfer & 
Goldfoot, 1966; Spanos, Horton, & Chaves, 1975).
It generally has been assumed that the perception of increased control options 
is stress-reducing whereas the perception of reduced control is stress-inducing (Averill, 
1973; Folkman, 1984). As was noted above, the perception of control generally often 
does appear to have beneficial effects in attenuating stressful experiences. However, it 
is now well known that providing increased control is not always desirable and that 
the relationship between perceived control and stress is more complex than formerly 
thought. Numerous experiments have demonstrated that when provision of control 
conflicts with a preferred coping style, the result may be increased rather than reduced 
distress (Andrew, 1970; Averill, O’Brien, & DeWitt, 1977; Mills & Krantz, 1979;
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Rosenbaum, 1980). A more recent example of how personality factors may impact the 
advisability of providing control is that of Miller & Mangen (1983), who in studying 
informational control effects, found that information seekers (monitors) were less 
distressed when given high information about an upcoming stressful medical procedure 
and information avoiders (blunters) were less distressed by low levels of information. 
Thus it appears that, at least in stressful circumstances, providing "control" that runs 
counter to a person’s preferred coping style may not only not be helpful but may be 
harmful to that individual.
In considering how the psychological construct of perceived control may 
operate in EMG-BF relaxation therapy, examination of a model of situational appraisal 
of stressful circumstances (Lazarus & Folkman, 1984) may be helpful. It is hoped that 
the model may provide a bridge toward understanding the operation of perceived 
control in less threatening circumstances. Relaxation training usually regarded as a 
low stress circumstance, however, the EMG-BF training situation may initially be 
perceived by the trainee as containing stressful elements, such as uncertainty about 
one’s ability to succeed at the specified task.
According to the Lazarus-Folkman model, a person in the primary stage of 
appraisal assesses the potential significance of the outcome of a situation and 
determines whether it is largely benign-positive or more likely to be stressful. If only 
positive or neutral outcomes are expected, the person does not interpret the situation as 
one that will exceed or substantially strain his/her coping resources and the situation 
is thus regarded as benign-positive. A situation appraised as stressful, however, is
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further broken down in the model into a harm-loss, threat, or challenge appraisal.
None of these appraisal categories are mutually exclusive and threat and challenge 
appraisals are particularly likely to co-occur. Just as beginning to attend college holds 
the potential both for performing below expectations and for gaining rewards such as 
new knowledge, skills, and career opportunities, the biofeedback situation, likewise, 
holds the possibility of failure to learn to relax and the possibility of mastering a new 
relaxation skill.
Situational judgements regarding control (perceived control) are part of 
secondary appraisal. The person’s beliefs about the possibilities for control in a 
specific encounter arise from the demands of the situation, their coping resources and 
options, and their ability to implement efficacious coping strategies. In secondary 
appraisal, which may co-occur with primary appraisal, the person evaluates his/her 
coping resources and options. These may include physical, social, psychological, and 
material assets that are compared with situational demands. Of particular relevance to 
the biofeedback situation are psychological and material resources. Psychological 
resources may include "hope-sustaining beliefs, self-esteem, skills, and morale" 
(Folkman, 1984). Material resources, include money, tools, and equipment. In the 
biofeedback situation, the EMG equipment, including the EMG signal itself, may thus 
be scrutinized for its usefulness in coping with or controlling the situation at hand (ie. 
the threat/challenge situation of learning to increase relaxation).
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Research Support for the Role of Cognitive Variables
A large body of research suggests that specific self-efficacy predicts behavior 
across a wide range of behaviors. The specific domains that have been examined 
include specific phobias (Bandura, Hardy, Adams, & Howells, 1980; Biran & Wilson, 
1981), social skills (Kazdin, 1981; Lee, 1984), vocational choice (Hackett & Campbell, 
1987), smoking cessation (Condiotte & Lichtenstein, 1981; Nicki, Remington, & 
MacDonald, 1984), recovery from heart attacks (Bandura, 1982), physical endurance, 
(Weinberg, Gould, & Jackson, 1979), and sports performance (Lee, 1982). In a study 
of an inpatient pain-management program (Kores, Murphy, Rosenthal, Elias, & 
Rosenthal, 1985) researchers found that high self-efficacy patients made significant 
gains over those with low self-efficacy in specific symptom improvement and in 
general improvement of outlook for the future.
A series of experiments in the mid 1980s (Andrasik & Holroyd, 1980;
Andrasik & Holroyd, 1983; Holroyd & Penzien, 1984), briefly described previously, 
provided support for the idea that increases in self-efficacy for self-regulation, rather 
than measurable somatic changes, may play a vital role in benefitting from 
biofeedback. In the first study (Andrasik & Holroyd, 1980) the researchers used 
contingent as well as false EMG-BF to teach tension headache sufferers to lower, 
raise, or stabilize their EMG levels. Regardless of actual EMG level, headache 
frequency and severity declined most for those subjects who perceived, or 
misperceived, that they had been successful in lowering their EMG levels. In a 
following study (Holroyd & Penzien, 1984) the researchers manipulated both the
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subjects’ perceived EMG levels and the accuracy of the reports of how successful they 
were in achieving significant EMG reductions. Subjects who were told that they were 
relatively effective, when compared with others, in reducing their EMG levels had 
significantly reduced headache activity, regardless of whether they had increased or 
decreased muscle tension levels. Those subjects who were told that they were 
performing poorly relative to the others did not have significantly reduced headache 
activity, even if they had been successful in reducing their EMG levels. Thus it 
appears that cognitive changes, such as enhanced perceptions of self-efficacy, rather 
than the direct effects of reduced somatic activity, may mediate reduced headache 
activity in EMG-BF tension-headache therapy.
To date, most of the research on perceived control and its relationship to self- 
efficacy expectations has focused on individuals responding to aversive or clearly 
stressful situations (Corah & Boffa, 1970; Cram, 1980; Averill, 1973; Carlson, 1982; 
Folkman, 1984; Holroyd & Penzien, 1984; Litt, 1988; Lundberg & Frankhaeuser,
1978) such as exposure to high levels of white noise, tension headaches, and cold- 
pressor tests. When subjects were given instrument control over the presence or 
absence of bursts of white noise (Glass, Singer, & Friedman, 1969) it was found that 
they experienced lower levels of discomfort than those without such control. In a 
similar design, these results were replicated in the following decade (Corah & Boffa, 
1970; Lundberg & Frankhaeuser, 1978). Corah and Boffa concluded that the choice 
variable and the increased perception of control it offers operates to reduce the 
aversive quality of the stimulus. In the only commentary of its sort found in a search
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of the literature, they suggest the research be broadened to include studies that do not 
involve obviously aversive consequences and note that appraisal of the consequences 
of an experimental situation will be mostly determined by the experimental conditions. 
In drawing on self-perception theory and analysis of other choice experiments (Bern, 
1965, 1967), if the experimental conditions include a measure of perceived control, 
then the subjects’ own behavior becomes one of the determining conditions of that 
appraisal.
By encouraging self-efficacy expectations and providing subjects with actual or 
apparent control over the instruments used in autogenic handwarming tasks (often used 
in the treatment of migraine), Litt (1988) found that subjects with perceived control 
over the instruments experienced a greater sense of confidence in their ability to 
regulate hand temperature and to tolerate cold than did those who had no option for 
control over the instruments. Those who perceived that they could control the 
instrument were also significantly more successful in raising their hand temperature. 
Additionally, Litt noted an interaction between self-efficacy and perceived control in 
that performance was maximal when both high levels of perceived control and self- 
efficacy were present.
A central question in studying the effects of perceived control and enhanced 
self-efficacy expectations as factors contributing to greater relaxation depth in EMG 
biofeedback therapy is the relationship of perceived control to self-efficacy in a 
challenging, rather than highly threatening, situation. Articles addressing these 
constructs individually have tended to ignore each other, with one area of investigation
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rarely drawing on the other. However, researchers in two separate studies of 
institutionalized elderly found that giving the patients more opportunities to make 
choices about their institutional environment was a predictor of increases in self- 
efficacy (Langer & Rodin, 1978; Schorr & Rodin, 1982), thus suggesting some level 
of interaction between perceived control and self-efficacy in more benign, rather than 
acutely threatening, situations.
In attempting to integrate the constructs of self-efficacy and perceived control 
one may postulate that the extent to which specific situationally based self-efficacy 
expectancies, rather than dispositional variables, determine the desirability of providing 
control should depend on the nature of the situation and how much the subject knows 
about it. Rotter (1966) conceived of generalized control expectancies, as opposed to 
situationally specific ones, as having the greatest influence in ambiguous or novel 
situations. Conversely, if the situation is well defined, specific self-efficacy should 
play a powerful role in mediating stressful or challenging experience.
If specific self-efficacy expectations do play an important role in mediating 
stressful/challenging situations as part of a secondary appraisal process, it should be 
possible to make fairly specific predictions about the interaction of perceived control 
and self-efficacy on performance during a stressful/challenging situation. If additional 
control is perceived to be available, and subjects have reasonably high outcome 
expectancies, then those subjects who have high confidence in their ability to use that 
control (high self-efficacy) should have better behavioral outcomes than those whose 
confidence is low. Additionally, if Bandura (1977) is correct, high-efficacy individuals
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should also experience less physiological arousal and less subjective stress than low- 
efficacy subjects. Bandura (1982) also suggests that highly efficacious individuals are 
more likely to choose control if that is an option. Low efficacious individuals should 
be not only less likely to choose controlling options but may experience greater 
distress and possibly anxiety, if coerced into using control that they feel unprepared to 
use.
Pilot Study: Effect of Signal Control on Biofeedback Outcomes
Although there is a notable body of research investigating the effects of 
perceived control and self-efficacy in coping with aversive situations, it has been noted 
that curiously little study has been directed toward such self-improvement tasks as 
EMG biofeedback relaxation therapy. In a pilot study (Prokop & Brown, 1988) it was 
found that providing instrumental control over the presence or absence of the EMG 
biofeedback signal resulted in significantly greater objective and subjective relaxation 
depth for those subjects with such control. The study did not address questions of 
perceived control or self-efficacy. In extending the investigation of the results of the 
above mentioned study, two possible explanations for the results should be explored.
The first possibility is that the mere awareness of the availability of a 
potentially useful resource (the ability to turn the signal on and off) in coping with the 
situation at hand was sufficient to elevate perceptions of control and self-efficacy 
expectations. Thus the increased perceived control and self-efficacy expectations 
(enhanced confidence in the ability to perform effectively) may have allowed more 
effective performance of the task. Because there were a relatively small number of
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subjects (22 in the signal-control group and 22 in the continuous-signal condition) it is 
also possible that more people in the experimental (signal-control) group had higher 
levels of self-efficacy before starting the experiment. As discussed earlier, Litt (1988) 
found that those subjects with higher levels of self-efficacy prior to beginning the 
experiment performed better at handwarming tasks than those with low pre-trial self- 
efficacy. Those with high self-efficacy in the choice condition outperformed all other 
groups.
An alternative explanation for the pilot study results is that those subjects with 
the ability to switch the signal on and off were able to make moment-to-moment self- 
efficacy judgements about their success in maintaining a relaxed state when the signal 
is absent. Those without control, however, had no means of objectively testing their 
ability to remain relaxed without the aid of the signal. While self-efficacy 
expectations may well increase in this group also, the expectations for success in 
relaxing, both with and without the aid of the signal, may be greater in the group that 
is able to make moment-to-moment comparisons between the signal on and signal off 
conditions. All subjects in the pilot study were told that the goal of biofeedback 
relaxation therapy is to be able to transfer the relaxation skills learned in the lab to 
situations outside the lab in which there will be no signal to guide them in their 
relaxation efforts.
Although this second explanation may have a greater appeal to a sense of 
parsimony, the previously outlined choice studies in which subjects were not instructed 
that they were learning a skill to be used outside of the lab (Averill, 1973; Corah &
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Boffa, 1970; Litt, 1988) nevertheless enhanced efficacy in performing the required 
tasks. These results and the Holroyd & Penzien (1984) findings of increased self- 
efficacy expectations in tension headache sufferers depending on their perception of 
their performance rather than on their actual performance are consistent with 
Bandura’s (1989) conclusions following a major review of the literature concerning 
self-efficacy and perceived control. He concluded that self-efficacy can play a major 
role in constructive behavior change and that awareness of a personal ability to control 
or cope with a particular situation is the major contributor to enhanced self-efficacy 
expectations.
If, as it appears, control over the presence or absence of the EMG signal serves 
to increase either objective or subjective relaxation depth in EMG-BF trainees then a 
clinical application of enhancing control cognitions has been uncovered. The addition 
to EMG-BF equipment of a switch controlling the presence or absence of the signal is 
a simple and inexpensive one and any demonstrated improvements in either subjective 
or objective relaxation depth warrant such an addition to all biofeedback relaxation 
equipment. Added control may also be beneficial in other types of biofeedback 
training such as muscle retraining after injury or stroke and in autogenic handwarming 
treatment of migraines. If the addition of a signal-control switch enhances control 
cognitions, self-efficacy, and/or relaxation in EMG-BF trainees then investigation of 
additional means of enhancing a sense of control and active participation is called for.
Should further study of providing signal control demonstrate that improvement 
is related to the ability to make moment-to-moment comparisons between the state of
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relaxation in on vs off conditions then justification for adding such control is equally 
compelling. The primary goal of EMG-BF training is to learn to generalize the 
relaxation skills learned in the lab to conditions in which there is no access to the 
signal. If what appears to be a simple skill-leaming process is enhanced by the 
addition of a control switch, however, such a finding does not preclude consideration 
of enhancement of control cognitions as a contributor to increased objective or 
subjective relaxation. If the ability to make moment-to-moment comparisons helps 
patients to increase both their relaxation level and/or their efficacy expectations for 
transferring the skills to outside of the lab, then, indeed, a useful clinical tool has been 
found.
Purpose, Hypotheses, and Theoretical Rationale
The purpose of the following study is to investigate the effect the provision of 
instrumental control over the presence and absence of the EMG signal on relaxation 
depth, self-efficacy beliefs and expectations, perceived control, and perceived signal 
utility. The design is a between-within study, with a blocking factor and two between- 
subjects factors (a treatment-control factor and a pre/post factor), and one post factor. 
The design incorporates three subject groups, including one experimental group and 
two control groups, one a "yoked-control" group and the other a traditional 
(continuous signal) BF group. Each group will consist of an equal number of both 
high and low self-efficacy subjects (determined on the basis of a median split of the 
screening scores). Those in the experimental (signal-control) group will be provided 
with an on/off switch and instructed that they may turn the signal on or off as they
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wish. Those in the yoked-control (intermittent-signal) group will receive EMG-BF 
intermittently. The intervals at which the experimenter will turn the signal off and on 
will be determined by taking an average of signal-on and signal-off interval lengths 
from 24 previously tested subjects from the signal-control group. This average 
interval length will be applied to 24 subjects in the intermittent-signal group. This 
procedure will be repeated for a second group of twenty-four intermittent-signal 
subjects in order to accommodate the 48 subjects in each condition and to avoid 
history effects that may occur if all 48 signal-control subjects are tested before any of
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the intermittent-signal subjects are tested. A continuous-signal group will attempt 
relaxation while receiving an uninterrupted EMG-BF signal.
Hypotheses:
(1) When compared with subjects in the continuous EMG condition, and those 
receiving intermittent feedback, those with signal control will experience lower 
objective (EMG) relaxation levels and an increased subjective sense of relaxation.
(2) Provision of instrumental control will be related to increases
in (a) self-efficacy for self regulation (b) perceived control, as reported on a scale 
composed of items that tap sense of control in the biofeedback situation, and (c) self- 
efficacy expectations, as measured on a self-efficacy expectations rating scale 
containing items that tap the subjects’ expectations for success at learning the EMG- 
BF relaxation technique.
(3) Subjects with signal-control will rate the signal itself as more useful in 
learning to relax than will those without control.
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(4) Subjects with high initial self-efficacy scores (regardless of assigned 
condition) will experience greater levels of objective and subjective relaxation than 
those with low self-efficacy scores.
If subjective and objective relaxation levels are higher in the experimental 
group than in the control groups, it is theorized that the added measure of control 
introduced is, alone, sufficient to increase both perception of control over the 
biofeedback situation and self-efficacy expectations, which, in turn, contribute to 
greater subjective and objective relaxation effects. Enhanced self-efficacy expectations 
may be influenced by the perception that one has been given an added measure of 
control (whether or not the control is implemented) or by the learning involved in 
making comparisons between signal-on and signal-off conditions.
Further explanation is warranted for the rationale behind adding a yoked- 
control group that receives experimenter controlled intermittent feedback. It was 
previously mentioned that it is possible that increased self-efficacy expectations and 
relaxation are largely due to a skills-learning process which may or may not be 
influenced by enhancement of control cognitions achieved by providing control over a 
switch. If increased relaxation effects are largely influenced by an enhanced learning 
situation, in which moment-to-moment comparisons between the signal-on and signal- 
off conditions are possible, then there should be little difference in relaxation depth 
between those receiving intermittent feedback and those who have signal control. In 
both groups, the subjects are exposed to conditions in which they can make 
comparisons. Additionally, there should be little difference between the two groups on
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measures of self-efficacy expectations and perceived utility of the signal. If, however, 
the experimental group develops significantly greater relaxation depth and scores 
significantly higher on perceived signal utility, on perceived control, and/or self- 
efficacy expectations than those without signal control, then the theory that relaxation 
depth is related to the cognitive effects of increased perception of control over the 
situation and enhanced self-efficacy expectations is supported.
Chapter 2 - Method 
Overview
Male and female subjects were recruited from the Introductory Psychology 110 
subject pool at the University of Montana. Subjects received a questionnaire 
(Appendix A) designed to screen out those with previous biofeedback experience, 
extensive experience with other relaxation techniques, or chronic high levels of muscle 
tension (eg. tension headaches and low back pain). Additionally, a scale was 
administered to screen subjects for high and low levels of self-efficacy for self­
regulation (Appendix B). Subjects were separated into high and low efficacy groups 
via a median split. From this pool, 144 subjects were contacted by phone. An equal 
number of high and low self-efficacy subjects were randomly assigned to one of the 
three following biofeedback conditions: (1) signal-control, in which subjects had 
control (in the form of an on/off switch) over the presence or absence of the 
biofeedback signal (2) intermittent biofeedback (interval length to be controlled by the 
experimenter) (3) continuous biofeedback. EMG relaxation level, subjective relaxation 
level, self-efficacy for self-regulation, self-efficacy expectation scores, perceived 
control scores, and perceived signal utility scores served as dependent measures. Each 
subject listened to both live and taped instructions on how to benefit from the audio 
signal and then underwent a 20-minute feedback session. The study was represented 
to the subjects as one in which the researchers are studying the effectiveness of 




Subjects were 144 undergraduate males (N = 72) and females (N = 72) 
recruited from introductory psychology courses and awarded course credit for their 
participation. Subjects were tested individually by experimenters who remained blind 
to both the hypothesis of the study and to the self-efficacy status of the subject. 
Apparatus and Materials
Audio biofeedback was provided by a J & J Industries MD500 
electro myograph (EMG) that was connected to a J & J Digital Integrator. Stainless 
steel Stoelting electrodes were attached using standard frontales muscle electrode 
placements. Prior to attachment, the subjects’ skin was lightly wiped with a sterile 
alcohol swab to ensure both sanitary conditions and proper microvolt conduction. 
Beckman electrode paste was used as the conducting medium, and impedance between 
any pair of electrodes was always below 10 k.
Median frontales EMG level was sampled during the last two minutes of a five 
minute pretraining period. This median value was the initial criterion level for the 
feedback, and this level of integrated frontalis EMG activity was accompanied by an 
auditory click rate of one per second. Activity above or below this level was 
accompanied by a proportional increase or decrease in the click rate. The feedback 
thus consisted of an auditory signal that varied in rate, in proportion to the integrated 
amplitude of the frontales EMG activity (above an adjustable threshold).
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Measures (See, also, Table 1: Schedule of Administration of Measures)
Objective Relaxation. EMG level was recorded on a J & J Industries MD500 
Digital Integrator and mean EMG levels in microvolts were calculated for each 20 
minute session after eliminating movement artifacts from the data. The criterion for 
removing movement artifacts is borrowed from Qualls and Sheehan (1984) and 
requires that the mean value from a 10 second period is more than double the mean 
value for the preceding 10 second period.
Subjective Relaxation. Subjective relaxation was measured by asking subjects 
to estimate their subjective sense of relaxation, as reported on a Likert-type scale, at 
two points: immediately prior to beginning the BF trial and just after ending the 20 
minute trial. The subjective relaxation Likert scale is reproduced in Appendix C.
Self-Efficacy for Self-Regulation. [Note: The following measures consist of 
scales designed to accommodate this particular study. Personal communication with 
Dr. Albert Bandura (March 18, 1992) and Dr. Mark Litt (March 18, 1992) has 
confirmed that there is no valid all-purpose measure of self-efficacy or perceived 
control. All-purpose measures usually have limited explanatory or predictive value 
because a fixed set of items may not have much relevance to the particular domain of 
functioning that is being studied. Moreover, in an effort to serve all purposes, items 
in an omnibus test are usually cast in a general form, leaving much ambiguity about 
exactly what is being measured. Scales measuring self-efficacy and perceived control 
should, therefore, be tailored to the particular domain of functioning that is of interest 
(A. Bandura, personal communication, March 18, 1992).
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Self-efficacy for self-regulation was measured using a scale composed of 10 
Likert-type scale items designed to tap an individual’s confidence in his or her ability 
to self-regulate physiological processes. This instrument is reproduced in Appendix B. 
There is as yet no tradition in the measurement of self-efficacy. Bandura (1986) has 
argued that self-efficacy expectations vary along dimensions of magnitude, generality, 
and strength. Magnitude refers to the ordering of tasks by level of difficulty and has 
until now been made operational by measuring perceived difficulty level (Strecher, 
Becker, Kirscht, Eraker, & Graham-Tomasi, 1985; Azjen & Timko, 1986). Generality 
is the extent to which self-efficacy expectations about a particular situation or 
experience are generalizable to other situations. Researchers have used samples of 
different situational items to assess generality (Nicki, Remington, & MacDonald, 1984; 
Coletti, Supnick, & Payne, 1985; DiClemente, Prochaska, & Gibertini, 1985; Strecher 
et al., 1985). The third dimension, strength, refers to a probabilistic judgement of how 
certain one is of one’s ability to perform a specific task. In most studies subjects have 
been asked to rate their confidence in accomplishing a certain task on a scale from 
minimum to maximum certainty (Condiotte & Lichtenstein, 1981; Nicki et al., 1984; 
Coletti et al., 1985; Bandura, 1986; DiClemente, 1986; Kok, deVries, Mudde, & 
Strecher, 1991).
It can,-however, be argued that self-efficacy can be seen as a perceived 
situation-dependent ability in relation to perceived task difficulty. Measurement of 
perceived difficulty does not necessarily imply an estimation of ability. A person can 
see a behavior in a certain situation as very difficult, but also as something that can be
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done. Measuring ability in relation to situational aspects, however, is likely to include 
perceived difficulty levels of both situation and behavior. A person asked to rate his 
or her confidence of being able to perform a certain behavior in a certain situation will 
probably weigh ability against task difficulty and situation difficulty. This leads to the 
conclusion that instruments designed to measure perceived ability, as is the scale used 
in this study, assess both the dimensions strength and magnitude. In the scale used in 
this study the inclusion of a sample of relevant self-regulation situations provides an 
assessment of the dimension generality.
Self-Efficacy Expectations for EMG-BF Competency. This scale is similar in 
construction to the Self-Efficacy for Self-Regulation Scale but contains items that 
directly query a subject’s expectation for success at the biofeedback task both in the 
lab and in stressful situations outside the lab. This scale is reproduced in Appendix D.
Perceived Control Scale. The perceived control scale ratings were made on an 
analog scale (Appendix E) that assesses the subject’s general sense of control in the 
biofeedback setting.
Perceived Signal Utility Scale. Perceived signal utility ratings were made 
along an analog scale (Appendix F) that is anchored at one end with not very useful at 
all and with very useful at the other. This scale was administered at the end of each 
of the 20-minute EMG-BF sessions.
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Table 1. Schedule of Administration of Measures
Measures Administered
Self-Efficacy for Self-Regulation (SESR) .....................................................Screening/Post
Objective Relaxation (E M G )....................................................................Pretrial/Continuous
Subjective Relaxation ( S R ) ...................................................................................... Pre/Post
Self-Efficacy Expectations (S E E S )................................    Pre/Post
Perceived Control (P C ).............................................................................................  Pre/Post
Perceived Signal Utility (PSU) ...................................................................................... Post
CONDITIONS
(1) Experimental Group = Signal-Control
(2) Yoked Group = Intermittent Signal
(3) Continuous Group = Continuous Biofeedback Signal
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Procedure
Subjects from Introductory Psychology 110 classes at the University of 
Montana were administered a questionnaire (Appendix A) designed to screen out those 
persons who have previously undergone biofeedback relaxation therapy and those who 
report current somatic complaints that may stem from or contribute to high levels of 
muscle tension. Although the latter group may be the population that would benefit 
most from biofeedback treatment, it was thought that persons without such somatic 
complaints would provide a more consistent baseline EMG level.
A pool of 144 subjects were contacted by phone and asked to take part in the 
study. Subjects were tested individually.
Each experimenter tested equal numbers of randomly assigned high and low 
self-efficacy male and female subjects in each treatment condition. Subjects were told 
that they were being asked to participate in a study of the effectiveness of taped vs 
live instructions in helping people learn to use the EMG-BF relaxation method. The 
experimenter further explained that a variety of pencil and paper measures would be 
used to help the experimenter determine how effective the EMG-BF method was for 
that individual. An exact script of the experimenter’s greeting and oral instructions is 
reproduced in Appendix H.
Before beginning the EMG-BF procedure, each subject was asked to sit quietly 
for two minutes in a comfortable reclining chair, after which completed the Self- 
Efficacy for Self-Regulation scale and rated their subjective sense of relaxation on the 
Subjective Relaxation Scale. Upon completing the scales they listened to a brief
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description of what EMG-BF is and how it is used to learn to relax. The experimenter 
pointed to the various pieces of equipment as they were discussed. In addition, 
subjects were told that EMG-BF therapy does not work for all people and that failure 
to learn to relax in response to the EMG-BF signal would not adversely affect their 
participation in the study.
The experimenter then attached the electrode headband using standard frontales 
muscle electrode placement. Subjects then listened to a 4-minute tape that instructed 
them on how to benefit from the biofeedback signal. The taped instructions were 
modified for each group in order to account for the differences in how the signal was 
delivered to each group. All groups were informed that a primary goal of EMG-BF 
relaxation therapy is to learn to transfer the relaxation skills learned in the lab to 
conditions outside of the lab in which the biofeedback signal is not available. A script 
of these tapes is reproduced in Appendix I.
The experimental group was told that the red switch, on the right arm of their 
Chair, turns the signal on and off and should be used to compare relaxation levels in 
the signal-on and signal-off conditions. They were instructed to try to remain relaxed 
in both the signal-on condition and signal-off condition. They were also instructed to 
leave the signal either on or off for about one minute at a time. This instruction was 
included in order to circumvent both the possibility that some subjects may rapidly 
cycle through the on/off conditions or leave the signal off for long periods of time, 
thus potentially hampering performance.
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The yoked-control (intermittent feedback) group was told that the signal would 
be turned on and off automatically and intermittently so that they could make the 
signal-on/signal-off relaxation comparisons. The continuous-signal group was told that 
the EMG signal would be continuous.
Before beginning a five-minute pretraining period all subjects completed a Self- 
Efficacy Expectations Scale and a Perceived Control Scale.
Each subject underwent a five-minute pretraining period in order to familiarize 
them with the procedure. At the end of this session the experimenter recorded the 
baseline integrated EMG level for the last 2-minutes of the 5-minute period and 
calibrated the equipment to the subject’s baseline EMG level.
The subject then began the EMG-BF session, which lasted for exactly 20- 
minutes. Following the 20-minute EMG-BF session and a two-minute rest period, the 
subject filled out, in the following order: (1) the Subjective Relaxation Scale (2) the 
Self-Efficacy for Self-Regulation Scale (3) the Self-Efficacy Expectations Scale (4) the 
Perceived Control Scale (5) the Perceived Utility Scale and (6) a post-experiment 
questionnaire (Appendix J) designed to determine the accuracy of prior information 
subjects may have had regarding the study or current suspicions about the true purpose 
of the study. The subjects were then told that, upon completion of the project, notices 
will be posted reminding them of their participation in the study and listing a phone 
number at which they can find out more about the study and a time and location at 
which the results of the study will be discussed. Finally, the subject was asked to
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refrain from discussing the study with other students and thanked for his or her
participation.
Chapter 3 - Results
Subjects who admitted to accurate suspicions about the nature of the study (N 
= 1), had prior experience with biofeedback (N = 7), or substantial experience with 
other forms of relaxation (eg. progressive relaxation, meditation) (N = 15) were 
excluded from the study. A total of 23 subjects were excluded.
The means and standard deviations for the dependent variables are presented in 
Tables 2-7. The standard deviations were large relative to the means for the variable 
EMG on the pre-test and smaller on the post-test. This is a predictable pattern and is 
explained in the Discussion Chapter.
The dependent variables (pre-post measures), Subjective Relaxation (SRI & 
SR2), EMG Relaxation (EMG1 & EMG 2), Self-Efficacy for Self-Regulation (SESR1 
& SESR2), Self-Efficacy Expectations (SEES1 & SEES2), and Perceived Control (PCI 
& PC2) were each subjected to individual repeated-measures ANOVAs (3 between- 
subjects by 1 within-subjects repeated-measures ANOVA). A two-way ANOVA was 
performed on the post-test dependent variable, Perceived Signal Utility. The results of 
all ANOVAs are listed in Tables 8-13. Where appropriate, the Student-Newman-Keuls 
multiple comparisons test was used to identify significant patterns of means.
The repeated-measures ANOVA for Subjective Relaxation by Condition by 
Confidence by Sex yielded a between-subjects main effect for Condition (F(2, 132) = 
4.13, p  < .018), but no significant between-subjects interactions were noted (see Table 
2 and Figure 1). A subsequent Student-Newman-Keuls (SNK) multiple comparisons 
test revealed that subjects with personal control over the biofeedback signal reported
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greater subjective relaxation at the end of the 20 minute biofeedback trial than those in 
either the intermittent or continuous feedback conditions. An interaction was observed 
for Sex by Time (F(l, 132) = 12.31, p < .001) in which females had lower initial 
scores on subjective relaxation but surpassed men on their final rating of relaxation.
A similar interaction was observed for Confidence by Time (F(l, 132) = 4.90, p <
.028) with less confident subjects reporting lower initial relaxation but exceeding 
confident subjects in mean levels of post-test relaxation (see Tables 2 and 8 and 
Figure 1).
A two-way ANOVA conducted on the post-test variable Perceived Signal 
Utility yielded a significant between-subjects main effect for condition, (F(2, 132)) = 
5.40, p  = < .006) and a main effect for gender (F(l, 4) = 5.67, p < .020), with 
females, as a group, rating the EMG signal as significantly more useful than did males 
(see Tables 3 and 9). A Student-Newman-Keuls multiple-comparisons test conducted 
on the group means for Condition revealed that the signal-control group (ie. the 
experimental group) reported the signal as significantly more useful in achieving 
relaxation than did the intermittent and continuous-signal groups (see Figure 2). There 
was no significant difference between the latter two groups. A trend toward 
significance for the interaction Sex by Confidence was noted (F(l, 132)) = 3.65, p < 
.060) (see Tables 3 and 9), with less confident males reporting the signal as more 
useful than did confident males and less confident females reporting the signal as 
slightly less useful than did confident females.
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The ANOVA for EMG by Condition by Confidence by Sex yielded no 
significant between-subjects effects or interactions. A within-subjects main effect for 
time was significant, (F(l, 132) = 89.69, p  < .001), indicating that, as a group, subjects 
were successful in significantly lowering their EMG level from baseline (see Tables 4 
and 10). There were no other significant effects.
The repeated-measures ANOVA for Self-Efficacy for Self-Regulation revealed 
no significant between-subjects main effects for Condition. However, a significant 
four-way interaction was found. The interaction of Condition by Sex by Confidence 
by Time (F(2, 132) = 4.03, p = < .020) reveals that the confident males and females in 
all conditions had relatively modest gains in SESR, although they generally started out 
higher than low confidence males and females (see Tables 5 and 11 and Figure 3).
The low-confidence males and females exhibited an unexpected pattern of interaction 
with Condition and Time. Low-confidence females in the signal-control group 
reported very low levels of SESR at pre and post-test relative to the other low 
confidence males and females in the other conditions, although there was a substantial 
gain from pre to post. Relative to the signal-control group males, who reported large 
gains in SESR from pre to post-test, low-confidence males in the intermittent and 
continuous signal groups exhibited relatively little increase from their moderate pre­
test SESR scores to post-test.
The repeated-measures ANOVA for Self-Efficacy Expectations (SEES) by 
Condition by Sex by Confidence reveals a trend toward significance for Condition 
(F(2,132) = 2.82, p < .063) with both the signal-control and continuous signal groups
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exhibiting similar SEES scores at post-test and those scores were higher than those of 
the intermittent-signal group. A significant main effect was noted for Confidence 
(F(l, 132) = 36.23, p  < .001) with low-confidence subjects experiencing greater gains 
in self-efficacy expectations for future success at the biofeedback task than those with 
initially high-confidence. A within-subjects main effect was noted for Time (F(l, 132) 
= 102.26, p < .001. A Confidence by Time interaction was also revealed (F(l, 132) = 
49.17, p  < .001) with low-confidence subjects experiencing greater self-efficacy 
expectation gains but high-confidence subjects scoring higher on both pre and post-test 
measures (see Tables 6 and 12 and Figure 4).
The repeated-measures ANOVA for Perceived Control revealed a significant 
main effect for Confidence (F(l, 132) = 45.75, p  < .001) and an interaction for 
Condition by Sex (F(l, 132) = 3.31, p < .040) (see Tables 7 and 13 and Figures 5 &
6). In the former, high-confidence subjects rated themselves higher in perceived 
control on both pre and post-test than did low-confidence subjects, although low- 
confidence subjects showed greater gains from pre to post. The interaction between 
Condition and Sex is noteworthy in that females with signal-control were somewhat 
more conservative in their ratings of Perceived Control at pre and post-test relative to 
females in the other two conditions whereas men in the signal-control condition 
exhibited the opposite trend and rated themselves higher in control at pre and post-test 
than did the males in the two other feedback conditions.
Tests for within-subjects effects and interactions for Perceived Control revealed 
a significant main effect for Time (F(l, 132) = 82.23, p < .001) (see Tables 7 & 13
and Figure 5). One significant within-subjects interaction was noted as well for 
Confidence by Time (F(l, 132) = 24.99, p < .001) indicating that the initially low 
Perceived Control scores for low-confidence subjects began to approach the higher 
scores of the high-confidence subjects (see Tables 7 & 13 and Figure 5).
Table 2. Means and Standard Deviations for Subjective Relaxation
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Cell Means and Standard Deviations for SR1 and SR2 
(Pre and Post Subjective Relaxation)
Female Male
Mean St Dev N Mean St Dev N
SR1a
EXP GRPb: +Conf 65.00 20.67 12 74.16 9.96 12
-Conf 56.25 18.70 12 66.67 13.00 12
INT GRPb: +Conf 67.50 12.88 12 69.16 17.29 12
-Conf 60.00 15.95 12 63.33 17.23 12
CTS GRPb: +Confc 65.83 13.11 12 62.50 14.85 12
-Conf 61.67 14.67 12 61.70 14.03 12
SR2a
EXP GRPb: +Conf 83.33 10.71 12 80.41 10.54 12
-Conf 83.00 14.82 12 86.67 10.73 12
INT GRPb: +Conf 77.91 8.40 12 74.17 10.83 12
-Conf 84.16 12.40 12 70.00 14.77 12
CTS GRPb: +Conf 75.00 9.05 12 75.83 9.03 12
-Conf 77.50 9.65 12 73.33 9.85 12
Combined Observed Means for SR1 and SR2
Mean SR1 N Mean SR2 N
EXP GRP 65.52 48 83.43 48
INT GRP 65.00 48 76.56 48
CTS GRP 60.41 48 75.41 48
OVERALL 63.65 144 78.42 144
SEX: Female 61.04 72 80.20 72
Male 66.25 72 76.73 72
CONF: +Conf 65.69 72 77.77 72
-Conf 61.60 72 79.16 72
CONF BY SEX: +Conf Females 62.77 36 78.75 36
-Conf Females 59.30 36 81.66 36
+Conf Males 68.61 36 76.80 36
-Conf Males 63.88 36 76.66 36
a) higher SR scores = greater self-reported relaxation
b) EXP, INT, CTS = Experimental, Intermittent, Continuous Groups
c) +Conf and -Conf = high and low self-efficacy for self-regulation
Table 3. Means and Standard Deviations for Perceived Signal Utility
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Cell Means and Standard Deviations for 
Post-Test Perceived Signal Utility (PSU)
Female Male
Mean St Dev N Mean St Dev N
PSUa
EXP GRPb: +Conf 83.75 15.09 12 74.60 7.90 12
-Conf 82.08 15.29 12 84.16 13.14 12
INT GRPb: +Conf 76.67 10.73 12 69.17 16.70 12
-Conf 78.33 15.85 12 67.92 16.71 12
CTS GRPb: +Conf 79.17 9.96 12 65.41 18.50 12
-Conf 70.83 14.43 12 75.83 14.88 12
Combined Observed Means for PSU
Mean PSU N
EXP GRP 81.14 48
INT GRP 73.02 48
CTS GRP 72.81 48
OVERALL 75.66 144
SEX: Female 78.47 72
Male 72.84 72
CONF: +Conf 74.80 72
-Conf 76.52 72
CONF BY SEX: +Conf Females 79.86 36
-Conf Females 77.08 36
+Conf Males 69.72 36
-Conf Males 75.97 36
a) higher PC scores = greater perceived utility of the signal
b) EXP, INT, CTS = Experimental, Intermittent, Continuous Groups
c) +Conf and -Conf = high and low self-efficacy for self-regulation
Table 4. Means and Standard Deviations for EMG Level
48
Cell Means and Standard Deviations for Pre and Post EMG Levels 
(EMG1 and EMG2)
Female Male
Mean St Dev N Mean St Dev N
EMG1a
EXP GRPb: +Confc 2.00 .90 12 2.18 1.31 12
-Conf 2.19 1.45 12 2.19 1.21 12
INT GRPb: +Conf 2.07 1.02 12 2.22 1.43 12
-Conf 1.97 1.04 12 2.21 1.62 12
CTS GRPb: +Conf 2.18 .85 12 2.22 1.27 12
-Conf 2.05 .80 12 2.16 .90 12
EMG2a
EXP GRPb: +Confc 1.63 .60 12 1.76 .60 12
-Conf 1.86 1.10 12 1.41 .50 12
INT GRPb: +Confc 1.68 .80 12 1.76 .80 12
-Conf 1.42 .85 12 1.86 1.30 12
CTS GRPb: +Conf 1.31 .40 12 1.38 .60 12
-Conf 1.33 .43 12 1.77 .95 12
Combined Observed Means for EMG1 and EMG2
Mean EMG1 N Mean EMG2 N
EXP GRP 2.14 48 1.66 48
INT GRP 2.12 48 1.68 48
CTS GRP 2.15 48 1.48 48
OVERALL 2.13 144 1.60 144
SEX: Female 2.08 72 1.54 72
Male 2.20 72 1.65 72
CONF: +Conf 2.15 72 1.60 72
-Conf 2.13 72 1.61 72
CONF BY SEX: +Conf Females 2.08 36 1.54 36
-Conf Females 2.07 36 1.50 36
+Conf Males 2.21 36 1.63 36
-Conf Males 2.18 36 1.68 36
a) lower EMG scores = greater relaxation
b) EXP, INT, CTS = Experimental, Intermittent, Continuous Groups
c) +Conf and -Conf = high and low self-efficacy for self-regulation
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Table 5. Means and Standard Deviations for Self-Efficacy for Self-Regulation
Cell Means and Standard Deviations for Pre and Post Self-Efficacy 
for Self-Regulation (SESR1 and SESR2)
Female Male
Mean St Dev N Mean St Dev N
S E S R f
EXP GRPb: +Confc 54.00 10.70 12 61.40 7.35 12
-Conf0 33.08 8.90 12 41.17 9.12 12
INT GRPb: +Conf 50.80 4.50 12 60.50 5.24 12
-Conf 39.33 5.05 12 47.00 5.84 12
CTS GRPb: +Confc 51.60 5.05 12 61.80 5.29 12
-Conf 36.33 6.63 12 48.91 8.11 12
SESR23
EXP GRPb: +Conf° 57.91 10.65 12 61.75 6.05 12
-Conf 42.83 12.40 12 54.41 9.40 12
INT GRPb: +Conf 52.25 5.10 12 61.00 4.90 12
-Conf 51.67 13.75 12 47.00 5.80 12
CTS GRPb: -i-Conf 54.25 7.25 12 62.58 5.10 12
-Conf 41.25 5.80 12 50.50 8.72 12






EXP GRP 47.08 48 54.22 48
INT GRP 49.04 48 52.97 48
CTS GRP 49.66 48 52.14 48
OVERALL 48.71 144 53.12 144
SEX: Female 43.97 72 50.02 72
Male 53.22 72 56.21 72
CONF: +Conf 56.47 72 58.29 72
-Conf 40.72 72 47.94 72
CONF BY SEX: +Conf Females 51.70 36 54.80 36
-Conf Females 36.25 36 45.25 36
+Conf Males 61.25 36 61.70 36
-Conf Males 45.19 36 50.64 36
a) higher SESR scores = higher self-efficacy for self-regulation
b) EXP, INT, CTS = Experimental, Intermittent, Continuous Groups
c) +Conf and -Conf = high and low self-efficacy for self-regulation
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Table 6. Means and Standard Deviations for Self-Efficacy Expectations
Cell Means and Standard Deviations for Pre and Post Self-Efficacy 
Expectations Scale (SEES1 and SEES2)
Female Male
Mean St Dev N Mean St Dev N
S E E S f
EXP GRPb: +Conf 66.67 11.72 12 77.50 13.70 12
-Conf 61.70 18.99 12 57.01 12.50 12
INT GRPb: +Conf 76.25 7.11 12 73.75 14.00 12
-Conf 53.75 8.80 12 54.17 9.96 12
CTS GRPb: +Confc 78.33 9.37 12 78.30 8.35 12
-Conf 65.00 13.14 12 60.00 14.32 12
SEES3
EXP GRPb: +Conf 75.00 12.43 12 80.42 11.76 12
-Conf 78.33 15.86 12 82.01 9.04 12
INT GRPb: +Conf 77.91 6.56 12 74.20 11.64 12
-Conf 76.70 8.87 12 65.00 6.74 12
CTS GRPb: +Confc 79.17 9.00 12 81.67 8.35 12
-Conf 75.00 9.04 12 71.25 14.32 12






EXP GRP 65.72 48 78.95 48
INT GRP 64.47 48 73.43 48
CTS GRP 70.41 48 76.77 48
OVERALL 66.87 144 76.39 144
SEX: Female 66.94 72 77.01 72
Male 66.80 72 75.76 72
CONF: +Conf 75.13 72 78.05 72
-Conf 58.60 72 74.72 72
CONF BY SEX: +Conf Females 73.75 36 77.36 72
-Conf Females 60.14 36 76.66 72
-i-Conf Males 76.52 36 78.75 72
-Conf Males 57.08 36 72.77 72
a) higher SEES scores = higher self-efficacy expectations
b) EXP, INT, CTS = Experimental, Intermittent, Continuous Groups
c) +Conf and -Conf = high and low self-efficacy for self-regulation
Table 7. Means and Standard Deviations for Perceived Control
51
Cell Means and Standard Deviations for Pre and Post Perceived 
Control Scale (PC1 and PC2)
Female Male
Mean St Dev N Mean St Dev N
PC1a
EXP GRPb: +Confc 68.33 17.49 12 78.33 10.30 12
-Conf 57.90 12.32 12 59.17 12.40 12
INT GRPb: +Conf 72.08 7.21 12 75.80 10.84 12
-Conf 56.67 7.78 12 55.00 9.05 12
CTS GRPb: +Conf 75.00 10.00 12 75.83 10.83 12
-Conf 61.67 8.35 12 58.33 9.37 12
PC2a
EXP GRPb: +Conf 73.33 18.74 12 80.83 12.40 12
-Conf 75.83 15.50 12 82.50 10.55 12
INT GRPb: +Confc 75.83 5.15 12 78.33 11.93 12
-Conf 77.50 10.55 12 59.17 15.64 12
CTS GRPb: +Conf 81.67 8.35 12 80.00 9.50 12
-Conf 70.00 10.45 12 68.75 11.70 12
Combined Observed Means for PC1 and PC2
Mean PC1 N Mean PC2 N
EXP GRP 65.93 48 78.12 48
INT GRP 64.89 48 72.70 48
CTS GRP 67.70 48 75.10 48
OVERALL 66.18 144 75.31 144
SEX: Female 65.27 72 75.69 72
Male 67.08 72 74.93 72
CONF: +Conf 74.23 72 78.33 72
-Conf 58.12 72 72.30 72
CONF BY SEX: +Conf Females 71.80 36 76.94 36
-Conf Females 58.65 36 74.44 36
+Conf Males 76.67 36 79.72 36
-Conf Males 57.50 36 70.13 36
a) higher PC scores = greater perceived control
b) EXP, INT, CTS = Experimental, Intermittent, Continuous Groups
c) +Conf and -Conf = high and low self-efficacy for self-regulation
Table 8. Analysis of Variance for Subjective Relaxation
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Analysis of Variance for Subjective Relaxation (SR)
Source of Variation SS DF MS F SIG of F
Between-Subjects Effects
Within Cells 33213.87 132 251.62
Cond 2078.30 2 1039.15 4.13 .018*
Sex 54.25 1 54.25 .22 .643
Conf 132.03 1 132.03 .52 .470
Cond by Sex 812.67 2 406.34 1.61 .203
Cond by Conf 380.53 2 190.26 2.02 .136
Sex by Conf 13.78 1 13.78 .15 .702
Cond by Sex by Conf 537.58 2 268.79 2.86 .061
Within-Subjects Effects (1Ime) for Variable SR
Within Cells 14546.87 132 110.20
Time 15827.17 1 15827.17 143.62 .001*
Cond by Time 485.60 2 242.80 2.20 .115
Sex by Time 1356.34 1 1356.34 12.31 o o *
Conf by Time 541.75 1 541.75 4.92
coCMO
Cond by Sex by Time 132.47 2 66.23 .60 .550
Cond by Conf by Time 611.63 2 305.82 2.78 .066
Sex by Conf by Time 14.67 1 14.67 .13 .716
Cond by Sex by Conf 246.00 2 123.00 1.12 .331
By Time
* = Significant
Table 9. Analysis of Variance for Perceived Signal Utility
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Analysis of Variance for Perceived Signal Utility (PSU)
Source of Variation SS DF MS F SIG of F
Between-Subjects Effects for Variable PSU
Within Cells 3415.62 4 853.90 4.25 .003*
Cond 2168.05 2 1084.03 5.40 .006*
Sex 1139.06 1 1139.06 5.67 .020*
Conf 108.50 1 108.50 .54 .463
2-Way Interactions 1030.72 5 206.14 1.03 .404
Cond by Sex 204.17 2 102.08 .51 .602
Cond by Conf 93.06 2 46.52 .23 .793
Sex by Conf 733.50 1 733.50 3.65 .060
3-Way Interactions 
Cond by Sex by Conf
726.34 2 363.19 1.81 .168
* = Significant
Table 10. Analysis of Variance for EMG Level
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Analysis of Variance for EMG
Source of Variation SS DF MS F SIG of F
Between-Subjects Effects
Within Cells 241.12 132 1.83
Cond .67 2 .34 .18 .832
Sex 1.10 1 1.00 .60 .460
Conf .00 1 .00 .00 .986
Cond by Sex .89 2 .45 .21 .784
Cond by Conf .19 2 .10 .06 .949
Sex by Conf .00 1 .00 .00 .951
Cond by Sex by Conf 1.66 2 .75 .41 .666
Within-Subjects Effects (1‘ime) for Variable EMG
Within Cells 30.30 132 .23
Time 20.59 1 20.59 89.69 .001*
Cond by Time 1.06 2 .53 2.31 .103
Sex by Time .01 1 .01 .02 .883
Conf by Time .02 1 .02 .07 .787
Cond by Sex by Time .70 2 .35 1.53 .220
Cond by Conf by Time .80 2 .40 1.75 .178
Sex by Conf by Time .03 1 .03 .12 .731
Cond by Sex by Conf .40 2 .20 .87 .432
By Time
* = Significant
Table 11. Analysis of Variance for Self-Efficacy for Self-Regulation
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Analysis of Variance for Self-Efficacy for Self-Regulation (SESR)
Source of Variation SS DF MS F SIG of F
Between-Subjects Effects
Within Cells 12411.88 132 94.03
Cond 1.69 2 .85 .01 .991
Sex 4163.28 1 4163.28 44.28
*oo
Conf 12468.84 1 12468.84 132.61 o O l
. *
Cond by Sex 315.75 2 157.88 1.68 .191
Cond by Conf 380.53 2 190.26 2.02 .136
Sex by Conf 13.78 1 13.78 .15 .702
Cond by Sex by Conf 537.58 2 268.79 2.86 .061
Within-Subjects Effects (1*ime) for SESR
Within Cells 3553.21 132 26.92
Time 1400.09 1 1400.09 52.01 O o L
. *
Cond by Time 233.36 2 116.68 4.33 .015
Sex by Time 145.92 1 145.92 5.42 .021*
Conf by Time 569.53 1 569.53 21.16 o o *
Cond by Sex by Time 102.53 2 51.26 1.90 .153
Cond by Conf by Time 185.08 2 92.54 3.44 .035*
Sex by Conf by Time 9.03 1 9.03 .34 .563
Cond by Sex by Conf 216.75 2 108.37 4.03 .020*
By Time
* = Significant
Table 12. Analysis of Variance for Self-Efficacy Expectations
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Analysis of Variance for Self-Efficacy Expectations (SEES)
Source of Variation SS DF MS F SIG of F
Between-Subfects Effects
Within Cells 25870.83 132 195.99
Cond 1104.34 2 552.17 2.82 .063
Sex 34.72 1 34.72 .18 .675
Conf 7100.35 1 7100.35 36.23
*8
Cond by Sex 839.76 2 419.88 2.14 .121
Cond by Conf 867.88 2 433.94 2.21 .113
Sex by Conf 555.56 1 555.56 2.83 .095
Cond by Sex by Conf 109.55 2 54.77 .28 .757
Within-Subjects Effects flIme) for Variable SEES
Within Cells 8412.50 132 63.73
Time 6517.00 1 6517.00 102.26
*oo
Cond by Time 578.30 2 289.15 4.54 .012*
Sex by Time 22.22 1 22.22 .35 .556
Conf by Time 3133.68 1 3133.68 49.17
*op
Cond by Sex by Time 278.30 2 139.15 2.18 .117
Cond by Conf by Time 196.00 2 98.00 1.54 .219
Sex by Conf by Time 1.39 1 1.39 .02 .883
Cond by Sex by Conf 460.60 2 230.30 3.61 .080
By Time
* = Significant
Table 13. Analysis of Variance for Perceived Control
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Analysis of Variance for Perceived Control (PC)
Source of Variation SS DF MS F SIG of F
Between-Subjects Effects
Within Cells 25488.54 132 193.10
Cond 563.20 2 281.60 1.46 .236
Sex 19.53 1 19.53 .10 .751
Conf 8833.42 1 8833.42 45.75 .001*
Cond by Sex 1277.08 2 638.54 3.31 .040*
Cond by Conf 802.78 2 401.39 2.08 .129
Sex by Conf 783.42 1 783.42 4.06 .056
Cond by Sex by Conf 409.03 2 204.51 1.06 .350
Within-Subjects Effects (Time) for Variable PC
Within Cells 9638.54 132 173.02
Time 6004.25 1 6004.25 82.23 .001*
Cond by Time 338.19 2 169.10 2.32 .103
Sex by Time 118.84 1 118.84 1.63 .204
Conf by Time 1825.10 1 1825.10 24.99 .001*
Cond by Sex by Time 375.69 2 187.85 2.57 .080
Cond by Conf by Time 504.86 2 252.43 3.46 .084
Sex by Conf by Time 4.25 1 4.25 .06 .810





















CONDITION BY CONFIDENCE BY TIME
[E, I, C = EXPERIMENTAL, INTERMITTENT, AND 
CONTINUOUS CONDITIONS]
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MAIN EFFECT FOR CONDITION
[E, I, C = EXPERIMENTAL, INTERMITTENT, AND CONTINUOUS CONDITIONS]
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CONFIDENCE BY TIME INTERACTION 
[+C, -C = HIGH AND LOW CONFIDENCE FOR SELF-REGULATION]
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[+C = HIGH CONFIDENCE, -C = LOW CONFIDENCE]
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Figure 6. Graph of Two-Way Between-Subjects Interaction (Perceived Control)
PERCEIVED
CONTROL
F E M A L E S
M A L E S
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Chapter 4 - Discussion
The signal-control condition produced the hypothesized superior levels of 
subjective relaxation and perceived usefulness of the signal as a relaxation aid. 
Additionally, as hypothesized, subjects with signal-control exhibited greater gains in 
self-efficacy for self-regulation from pre to post-test than did subjects in the 
intermittent and continuous-signal groups. All conditions produced significant pre-post 
positive changes in EMG relaxation, however, the signal-control condition did not 
differ significantly from the intermittent and continuous-signal conditions in the 
amount of change. As was noted in the introduction to this study the accumulated 
research focused on self-regulation has indicated that the perception that one has been 
successful at a self-regulatory task may be a more potent factor in yielding greater 
relaxation or symptom improvement than is actual success at physiological change 
(Cram, 1980; Holroyd & Penzien, 1984; Katz, Simkin, Beauchamp, & Mattson, 1987; 
& Litt, 1988).
The finding that both self-reported relaxation and perceived utility of the signal 
in achieving relaxation were highest in the signal-control condition would seem to rule 
out the worrisome possibility that subjects felt more relaxed in this group simply 
because they were able to leave the signal off for long periods of time. Additionally, 
the fact that the intermittent-signal group was "yoked" to the signal-control group by 
using averaged signal-on and signal-off times from the signal-control group suggests 
that having the signal periodically absent was not an influential factor in achieving 
relaxation. At least one study has shown that subjects who rank high in the
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characteristic of "absorption" or the preference for internally generated cues for 
relaxation may find that the biofeedback signal initially impedes the use of their 
preferred relaxation method (Qualls & Sheehan, 1984). Persons with this 
characteristic are found relatively infrequently in the general population and are 
unlikely to have had a significant impact in this study.
One explanation for the positive effect of signal-control on subjective 
relaxation, perceived signal utility, and self-efficacy for self-regulation is that there 
was some advantage gained by being able both to make comparisons between the 
signal-on and signal-off conditions and having control over this procedure. It is in 
attempting to explain this finding that the "yoked" intermittent-signal group becomes 
especially important. They too had the signal turned on and off at various points 
during the trial but unlike the signal-control group had no control over the times at 
which the signal was turned on or off. As was theorized in the introduction to the 
study, subjects may find it enlightening or encouraging to turn the signal off and find 
that when they turn the signal back on their frontales muscles have remained relatively 
relaxed. Why the intermittent-signal group seemed not to be similarly encouraged is 
unclear but it is possible that having the signal turned on and off by the experimenter 
either failed to foster a sense of mastery or was even found disempowering or 
irritating to those subjects. An addition to this study that might help further explicate 
this question would be the Profile of Mood States (POMS) measure administered pre 
and post-test to determine whether frustration or irritation figured in the differences 
found. It should be noted that the signal-control group and the continuous-signal
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group exhibited greater gains in subjective relaxation from pre to post-test (change =
18 and 15, respectively) than did those in the intermittent-signal group (change = 11.5) 
suggesting some disadvantage to an experimenter-controlled signal.
A final observation with respect to self-reported relaxation is that women 
showed greater gains in subjective relaxation from pre to post-test and less confident 
subjects made not only greater gains in subjective relaxation but rated themselves as 
slightly more relaxed at post-test than did more confident subjects. Additionally, less 
confident subjects in the signal-control group made the largest gains in subjective 
relaxation and this confidence factor appears notably more influential than was gender 
on improvement from pre to post-test. A glance at the means for Confidence by Sex 
(see Table 2) shows that the group comprised of less confident female subjects made 
the greatest overall gains in relaxation and were exceeded in final relaxation levels 
only nominally by the signal-control group. Among the possible explanations for the 
disproportionate gains made by low confidence subjects and by females is that these 
gains may be a function of higher initial levels of perceived tension (ie. low initial 
subjective relaxation) that are either endogenous in these groups or are precipitated by 
apprehension about the prescribed biofeedback task. There is research that supports 
this speculation in which perceived autonomic arousal varied directly with self-efficacy 
for success at a difficult motor skills task and females rated higher than males on 
anxiety prior to attempting the task (Feltz, 1988). It is also possible that the low 
initial scores posted by the low confidence subjects on subjective relaxation, self- 
efficacy for self-regulation, self-efficacy expectations, and perceived control are a form
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of a priori excuse making that serves a defensive role should the person perform 
poorly. The finding that females rated themselves lower in self-efficacy for self­
regulation than did males is unsurprising since there is ample research evidence that 
females’ self-efficacy for motor skills tasks tends to decrease from adolescence into 
adulthood and males exhibit the opposite trend (Hackett & Campbell, 1987; Lee & 
Austin, 1986; Petruzzello & Corbin, 1988; & Wittig, Duncan, & Schurr, 1987).
A pattern was noted for females to make significantly greater gains than males 
and for less confident subjects to make greater gains than more confident subjects not 
only on subjective relaxation, but on perceived signal utility, self-efficacy for self­
regulation, and perceived control as well. This finding is in agreement with recent 
studies investigating cognitive factors and their impact on performance (Courneya & 
McAauley, 1993; Latham, Winters, & Locke, 1994) and at odds with several other 
studies that have found that high efficacy levels were associated with larger 
performance gains or symptom improvement (Lee, 1982; Kores et al., 1985). While it 
is tempting to conclude that biofeedback appears to be most beneficial for women with 
low confidence in their ability to self-regulate, it is important to note that post-test 
scores did not vary dramatically among groups and that on measures such as the Self- 
Efficacy for Self-Regulation Scale males and confident subjects rated themselves as 
significantly more efficacious at self-regulation than did any other groups. Still, it 
may be that subjects who have low initial levels of confidence in their own ability to 
self-regulate find the objective feedback provided by an EMG more encouraging than
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do already confident subjects who almost by definition seem to need less external 
verification of their ability.
The fact that EMG levels were not differentially affected by feedback condition 
is of special interest since a previous 1-trial study found that signal-control subjects 
achieved significantly lower EMG levels than did continuous-signal subjects (Prokop 
& Brown, 1988). In that study, however, the feedback trial lasted only 8 minutes 
rather than 20 minutes. If EMG level tended to rise during the signal-off periods then 
any significant differences between conditions during signal-on periods might be 
obscured. Because both signal-on and signal-off performance was integrated 
throughout the trial it was not possible to tell whether feedback performance suffered 
during the signal-off condition. In the previous study (Prokop & Brown, 1988) EMG 
output was recorded for only eight minutes and subjects were instructed to leave the 
signal off for an estimated 10 seconds whereas subjects in this study were given no 
such instructions and averaged nearly 30 seconds for each signal-off period. If 
performance suffered during the signal-off condition then higher performance during 
the signal-on condition might be hidden as the lower performance periods contributed 
to the averaged EMG levels. If performance did, indeed, suffer during the signal-off 
condition then the fact that the continuous-signal group achieved a lower average 
EMG level than either the signal-control or intermittent-signal group might be 
explained. Future studies could avoid this potential pitfall by modifying the EMG or 
integrator so that only signal-on EMG is recorded or by programming a computer to 
discretely record both signal-on and signal-off average EMG levels.
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It was noted in the Results Chapter that variance for baseline EMG levels was 
quite high for all conditions and somewhat lower for the 20 minute averaged EMG 
levels. Because there is great variation found in baseline frontales muscle tension in 
the general population (Hatch, 1990) high standard deviations for baseline EMG are 
found in most studies. Standard deviations for EMG levels after practice generally 
become smaller as the majority of biofeedback subjects with high baseline EMGs are 
able to reduce their 20 minute integrated EMGs to levels that approach those 
integrated levels of subjects with low baseline EMGs. Most subjects in this study 
were successful at lowering their EMGs to below 2.5 microvolts whereas initial EMGs 
of 4.0 and higher were common.
The hypothesis that subjects with high confidence (SESR) at the time of 
screening (regardless of assigned condition) would experience higher levels of EMG 
relaxation and subjective relaxation than those with low confidence scores was not 
supported. High initial confidence was related to higher final levels of perceived 
control, self-efficacy expectations for success at the specific task, and self-efficacy for 
self-regulation. This is not a particularly revelatory finding, however, since these 
measures tap similar constructs and high confidence subjects would be unlikely to 
experience a decline on these factors unless, as a group, they had performed poorly at 
the biofeedback task.
A complicated interaction was the four-way interaction Condition by Sex by 
Confidence by Time for the variable Self-efficacy for Self-Regulation (SESR) (see 
Figure 3). However, this unexpected interaction may be less daunting to interpret than
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it first appears. The outstanding feature is that initially less confident females in the 
signal-control condition rated themselves quite low in SESR relative to all other 
groups whereas less confident females in the continuous-signal condition rated 
themselves dramatically higher in SESR and females in the intermittent group fell 
about midway between. Because all subjects were aware of what their task consisted 
prior to beginning biofeedback relaxation, it is possible that low confidence females 
found the idea of an aid to EMG relaxation performance onerous and/or threatening.
Other studies have demonstrated that the addition of factors that are perceived 
as aids to accomplishing a particular task are likely to boost self-efficacy beliefs and 
expectations so long as the aid(s) appears to be credible and easily used (Bandura, 
1989; Corah & Boffa, 1970; & Litt, 1988). Research indicates that provision of aids 
to success are sometimes regarded as threatening. The frequent presumption is that if 
the perceived utility of the aid is not potent enough to override low self-efficacy 
expectations then the person puts him or herself at risk for lowering self-efficacy by 
failing at the task, even when additional resources are provided. The fact that low 
confidence signal-control group females rated themselves considerably lower at pre­
test on SESR (than did low confidence females in the other conditions) strongly 
suggests that the low confidence female signal-control subjects were not encouraged 
by the prospect of having added control over the biofeedback signal. A similar, 
though non-significant, pattern was also noted for self-efficacy expectations (SEES).
Subjects, as a whole, reported significant increases in perceived control but the 
hypothesized superior perceptions of control over the biofeedback process for the
71
signal-control group were absent. It thus appears that either the measure aimed at 
tapping perceived control had little discriminant validity for the type of control of 
interest in this study or the conditions had little influence on perceived control. 
However, the measure of perceived utility of the signal (for achieving relaxation) did 
discriminate between groups and may ultimately be a more interpretable and precise 
device for operationalizing perceived control than was the control measure employed 
in this study.
An interesting result of this study was the interaction of Condition by Sex by 
Time on perceived control scores. Females in the intermittent-signal group scored 
marginally higher on perceived control than did females in the other conditions.
Males in the intermittent group, however, scored significantly lower in perceived 
control, with the males in the signal-control group scoring highest. One interpretation 
is that males found the experimenter-controlled intermittent signal in some way 
disempowering, whereas females had an opposite response. Whether this difference is 
an extension of cultural experiences of comfort or discomfort with allowing others to 
wield control is not clear. An alternative explanation is that there was also an 
interaction between gender of the experimenter and perceived control. That is, 
females may have felt more comfortable in relinquishing signal-control to the 
exclusively female experimenters than did males.
To summarize, it appears that the provision of signal-control to biofeedback 
relaxation trainees is warranted in that signal-control can confer some measurable 
increase in subjective relaxation, appreciation for the usefulness of the audio signal in
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achieving relaxation, and self-efficacy for self-regulation. Signal-control does not, 
however, appear to confer any incremental short-term advantage over the other 
condition in learning to relax the frontales muscles. It may be said with confidence 
that signal-control does no harm to EMG relaxation nor has a negative influence on 
the cognitive variables addressed in this study. Additionally, the expense and 
difficulty of adding a signal-control switch is negligible and even small gains in 
subjective relaxation, self-efficacy, and perceived control would warrant the addition 
of a control switch to EMG relaxation equipment. A caveat to adding signal-control is 
that low confidence females appear to be at some initial risk for perceiving signal- 
control as burdensome or threatening. It may be that identification of low self- 
efficacy females and allowing them to start learning biofeedback relaxation in the 
continuous-signal condition would be prudent.
The results of this study suggest several directions for future research. The 
unexpected impacts of low confidence and gender on outcome of biofeedback 
relaxation training are intriguing and the preceding attempts to explain these effects go 
little beyond speculation. If gender and confidence play an important role in 
enhancing or detracting from the biofeedback relaxation experience then it would be 
helpful to know what factors might augment or mitigate the impact of these two 
variables. Additionally, researchers attempting to extend the findings produced by this 
study would be well-advised to modify the method so that signal-on and signal-off 
EMG levels are discretely recorded. Given several interactions including gender as a 
factor, it would also be prudent to assign equal numbers of male and female subjects
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to equal numbers of male and female experimenters. It may also be helpful to go 
beyond the finding that signal-control subjects found the signal particularly helpful and 
elucidate what aspects of signal-control the subjects found useful.
Central to continued research in the field of EMG-mediated relaxation should 
be the question that has been explicit and implicit throughout this thesis, "In what 
form and manner should biofeedback be offered to best interact with the self-efficacy 
beliefs and temperament of the individual biofeedback trainee?"
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Appendix A - Biofeedback Questionnaire
Please answer the following questions by circling the correct response.
(1) Have you ever received biofeedback therapy for tension headaches, migraine 
headaches, general relaxation, or for any other purpose?
(Yes) (No)
(2) Have you ever become proficient at other relaxation techniques (such as 
progressive relaxation or meditation)?
(Yes) (No)
(3) Do you currently suffer from any of the following: Frequent (more than 2 per 
week) tension headaches, migraine headaches, backache, or any other chronic pain?
(Yes) (No)
(4) Are you currently taking any muscle relaxant medication? 
(Yes) (No)
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Appendix B - Self-Efficacy for Self-Regulation Scale*
*(no titles on actual measures)
0 10 20 30 40 50 60 70 80 90 100
Can’t Moderately Certain
do at certain can do
all can do
Using the scale above please rate your confidence that you can accomplish the tasks 
listed below. (If you are not sure of your 
ability, please make a guess).
Confidence
(0- 100)
(1) When I feel anxious, I can calm myself down. ______
(2) I can slow my heart rate voluntarily. ______
(3) By concentrating on being calm, I can keep myself 
calm in stressful situations.
(4) I can lower my blood pressure voluntarily.
(5) When I am very excited, I can slow down my breathing.
(6) I can talk myself out of getting sick when I feel a 
cold coming on.
(7) When my stomach begins to growl, I can control it 
for a little while (without eating anything).
(8) I can slow my breathing down if I ’m moderately 
excited.
(9) When I’m too cold, I can talk myself into feeling 
warmer.
(10) When I’m too warm, I can talk myself into feeling 
cooler.
Appendix C - Subjective Relaxation Scale
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0 10 20 30 40 50 60 70 80 90 100
Not Moderately Completely
at all relaxed relaxed relaxed
Using the scale above, please answer the following questions.
Relaxation Level 
(0- 100)
How relaxed do you feel on a daily basis (average)? ________
How relaxed do you feel right now?
88
Appendix D - Self-Efficacy Expectation for EMG-BF Competency Scale
0 10 20 30 40 50 60 70 80 90 100
Using the scale above, please answer the following questions.
I can do the basic task described in the biofeedback 
instructions (lowering my muscle tension levels).
Using the biofeedback technique learned here I will be 
able to lower my tension levels in stressful situations 
outside of the biofeedback lab.
Please answer the following question. (Circle the answer).










One day or less One week One month One year Over a year
Appendix E - Perceived Control Scale
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Please use the scale above to answer the following question.
Amount of control 
(0- 100)
How much personal control do you feel that you have in 
learning to use the biofeedback equipment? (Please note 
that this question does not refer to being required to 
participate in experiments but is directed toward
your feelings of control oyer the biofeedback process). ______
Appendix F - Perceived Signal Utility Scale
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Please use the above scale to answer the following question.
Usefulness
(0- 100)
How useful was the EMG audio signal in helping you
learn to relax? _____
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Appendix G - Informed Consent Form
"The Effect of Taped Instructions on Biofeedback Relaxation"
Principal Investigator: David Brown 
Under the Direction of Balfour Jeffrey, Ph.D.
University of Montana
I understand that in signing my name below, I give my informed consent to participate 
in this study.
(1) The procedures to be followed include completion of several brief questionnaires, 
listening to taped instructions on the use of the biofeedback signal in learning to relax, 
and undergoing approximately 40 minutes of EMG biofeedback relaxation training and 
practice.
(2) All information you provide will be treated with the utmost confidentiality. Your 
name will not be associated with any of the collected data. You will be identified in 
the data only by number.
(3) You will receive 2 experimental credits for participating.
(4) You are free to refuse to participate or to discontinue participation at any time, 
without prejudice to you and without jeopardy to any credits that you have earned.
(5) After the study has been completed, you have the opportunity to be informed of 
the results, and questions that you may have will be answered at a debriefing meeting 
(Time and location will be announced at several campus locations). You may also 
contact the Principal Investigator, David Brown, at 1-777-3555 (evenings). For 
reasons of confidentiality, no specific information can be provided about you or any 
other participating individual.
I HAVE READ AND UNDERSTOOD THE ABOVE AND AGREE TO 
PARTICIPATE IN THIS STUDY.
Participant Date
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Appendix H - Experiment Instructions
(Experimenter’s Script)
E: "Hi (subject’s name), I’m (experimenter’s name). I am Dr. Jeffrey’s and David 
Brown’s research assistant. How are you today...? [Keep conversation brief, pleasant, 
and professional.] I’d like for you to read and fill out this questionnaire and consent 
form. Please have a seat right here and we’ll get started."
[Seat the subject in the upholstered chair and collect the questionnaire and informed 
consent form when he/she is finished].
"First of all, I want to thank you for participating in this study. You have 
signed up for an experiment for which you will receive 2 experimental credits. I will 
not be able to answer questions about the study itself while you are actively 
participating, but I’d like for you to ask questions if there are instructions that are not 
clear to you. As you may already know, this study involves learning to relax using 
biofeedback equipment. We’re interested in the effectiveness of different types of 
biofeedback relaxation instructions in helping people to benefit from biofeedback.
This will help us to know which types of instructions to use or in future biofeedback 
relaxation treatment. I’d like to tell you briefly how we will proceed."
"We will be doing three basic tasks in this session. (1) At several points 
during the session I will ask you to answer questions with pencil and paper. (2) You 
will spend a few minutes learning what biofeedback is and how it is used for 
relaxation. Then you will spend 5 minutes listening to taped instructions on how to 
use the biofeedback signal to help you to relax. (3) About 25 minutes total will be 
spent in learning to relax by using the biofeedback equipment. The first 5 minutes 
will be a pretraining period after which you will spend 20 minutes using biofeedback 
to help you relax. O.K.?"
E: "First, I’m going to leave the room for a few minutes and while I ’m gone, I’d like 
for you to stay seated in this chair, close your eyes, and relax as well as you can for 
two minutes. At the end of two minutes I will come back into the room and we will 
continue."
[The experimenter leaves the room and returns after 2 minutes. The subject then fills 
out the Subjective Relaxation Scale and the Self-Efficacy for Self-Regulation Scale. 
The experimenter collects the materials and sets them aside].
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E: "Now I’d like to tell you a little bit about biofeedback and using it for relaxation. 
Biofeedback equipment is used to measure a particular biological state, such as your 
body temperature or levels of tension in your muscles. In this case we will be 
working with muscle tension. The reason it is called feedback is that your muscle 
tension level is electronically converted into a clicking or beeping signal that you can 
hear and it lets you know whether your muscle tension level is changing and how 
much it is changing.
In the type of biofeedback we will be using, these little sensors (experimenter 
shows subject the electrodes) will sense the muscle tension level in your forehead 
muscles and the biofeedback machine" (experimenter points to the EMG myograph) 
turns the muscle tension into a signal that you can hear. The signal will sound like 
soft beeping noises. This beeping will speed up when your muscles are tensed and 
slow down when your muscles are relaxed.
The idea behind biofeedback relaxation is to concentrate on relaxing the 
muscles in your forehead and to use the beeping noise as a guide to tell you how well 
you are doing. The more relaxed you get, the slower the beeps. We will start the 
biofeedback session in a few minutes, after you have listened to some taped 
instructions.
Before we begin I want to let you know that biofeedback relaxation does not 
always work for all people and that if you have any difficulty in relaxing with 
biofeedback it will not adversely affect your participation in our study. O.K.?"
E: "Now, I’d like to have you listen to a tape that is designed to help you learn to 
relax while listening to the biofeedback signal. This will take about 4 minutes."
E: "I’d like for you to use these to listen to the tape.
After you put them on please rest your head on the headrest and get as comfortable as 
possible. When you are ready, push "play" and listen to the tape straight through 
without stopping."
[Subject begins the tape and the experimenter leaves the room for 5 minutes.]
[The script of this tape is located in Appendix I along with an addendum that lists the 
variation in the tape for each group.]
E: (Returning after 4 minutes) "Before we begin I would like for you to fill out two 
more brief forms."
[Subject fills out the Self-Efficacy Expectation Scale and Perceived Control Scale. 
Experimenter collects the materials and sets them aside].
E: "If you are ready to begin, I will attach the sensors and then I’d like you to spend 
the next 5 minutes learning how to use the signal, after which I will adjust the 
equipment to your baseline level of tension. I will let you know when 5 minutes have
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past. [**** Read this to the subjects in the "switch group" only.**** "Remember to 
avoid using the switch during this 5 minute training period"].
E: "I also want to assure you that all of this equipment is battery operated and is 
perfectly safe. In order to ensure good contact for the sensors I will need to wipe 
your forehead lightly with alcohol and use a sterile contact gel in each sensor. Is this 
O.K. with you?"
[With permission, the experimenter attaches the electrodes to the three frontales points 
on the subjects forehead and the subject begins the relaxation practice].
[Upon returning, the experimenter turns off the signal and calibrates the EMG to the 
subject’s baseline EMG activity for the last 2 minutes of the training period.]
E: "For the next 15 minutes I want you to use the biofeedback signal to become as 
relaxed as you can. At the end of the 20 minutes, I will turn off the signal and then I 
would like for you to continue to relax for a couple of minutes. I’ll let you know 
when two minutes are up. Remember, keep your eyes closed, stay as relaxed as 
possible, and remember the instructions on the tape."
[Experimenter turns on the signal and closes the partition to give the subject privacy. 
(1) For the signal-control group, the experimenter records the interval lengths for the 
signal-on/signal-off conditions. (2) For the intermittent-signal subjects, the 
experimenter quietly turns the signal on and off according to the schedule generated 
by the signal-control group’s average intervals. After 15 minutes have passed, the 
experimenter turns off the signal, records the integrated EMG level, reminds the 
subject to continue to relax for a couple of minutes, after which the subject fills out 
the remaining measures, ie. the SR, PSU, SESR, SEES, and PC scales. The 
experimenter collects the packet and places it in the file folder.]
[The experimenter detaches the electrodes, thanks the subject for his/her participation, 
and tells the subject about the notice that will be posted listing the dates and location 
for the debriefing session.]
A transcript of the notice is reproduced in Appendix K.
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Appendix I - Script of Taped EMG Biofeedback Relaxation Instructions
[Includes addendum listing the variations in each tape]
"You’ve already learned quite a bit about what biofeedback is and how it 
works. Let’s learn more about it and how to get the most relaxation out of it. Keep 
in mind that your task is to try to keep the beeping tone as low and slow as possible 
by relaxing the muscles in your forehead. First of all it helps most people to hear a 
little bit about how to relax before the biofeedback signal begins. During the 
biofeedback session keep your eyes closed and your jaw muscles slack. It is also very 
important to find a comfortable position in the chair, to have your head well 
supported, and to refrain from moving during the session.
You may find it helpful to breathe moderately deeply and slowly. After the 
beeping signal comes on, some people find that simply concentrating on the 
biofeedback signal and using the signal to deepen their relaxation works well. Others 
find that they do better if they imagine some peaceful scene or activity. Some of the 
images people have found helpful in relaxing are floating in a warm lake with gentle 
ripples or lying on the beach in the warm sun and hearing the regular sound of the 
waves and feeling the warm breeze. Imagining a favorite place where you always feel 
comfortable is often helpful.
For many people, however, simply concentrating on slowing and lowering the 
tone of the signal is helpful in relaxing and using imagery is not always necessary. 
When we start the 5 minute biofeedback pretraining session, try to find the strategy 
that works best for you and then stick with it. It is not unusual to find that you will 
reach a point at which you can’t get the beeping tone to go any slower or any lower.
If that happens, just try to keep the beeps at that low and slow level. O.K.?
One other thing we would like to mention before you begin the session is that 
one of the goals of biofeedback relaxation therapy is for you to be able to transfer the 
relaxation skills learned here in the lab to situations outside of the lab in which muscle 
tension levels are high. In other words the ultimate goal is not only to train yourself 
to relax by using the signal but to be able to relax without the use of the signal.
[At this point the taped instructions will vary in content according to which group the 
subject has been assigned to.]
Experimental (signal-control) group’s instructions are as follows:
One of the means by which you might tell whether or not you will be able to 
use the relaxation technique learned here for conditions in which you wish to relax 
outside of the lab is to turn the signal off occasionally and then turn it back on to see 
if it is still beeping at a level as low and slow as when you turned it off. In order to
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allow you to turn the signal on and off, we have installed a red switch on the right 
arm of your chair. You can use this button to turn the signal on and off. During the 
5 minute pretraining session which we will begin shortly, we need to adjust the 
equipment and we ask you to refrain from using the on/off button. Once the 20 
minute session begins we ask that you try to remain as relaxed and calm as possible 
while pushing the button. We also would like for you to leave the signal on or off for 
30-60 seconds at a time. When you turn the signal off, remember to continue your 
specific efforts to relax.
Intermittent-signal group’s instructions are as follows:
One of the means by which you might be able to tell whether or not you will be able 
to use the relaxation technique learned here for conditions in which you want to relax 
outside of the lab is to have the signal periodically turned off and on. This 
biofeedback equipment is wired so that the signal, or beeping tone* will disappear and 
then reappear periodically. This pattern will be repeated throughout the rest of the 
session. The signal will remain on or off for at least 25 seconds at a time. Try to 
remain relaxed during those periods in which the signal is on and those in which the 
signal is off.
Continuous-signal group instructions:
"Once the signal comes on, it will remain on for the entire session. Try to remain as 
relaxed as possible during the whole time period."
[End of special instructions]
"Now that you have listened to this tape we are almost ready to begin the 20-minute 
biofeedback session."
Appendix J - Post-Experiment Questionnaire
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Do you think the experimenter was interested in something other than what she/he 
said she/he was interested in?
If so, what do you think was the purpose of the study?
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Appendix K - Debriefing Announcement
Attention: Former Introductory Psychology Students
For those students who participated in the Biofeedback Study conducted by 
David Brown and Dr. Jeffrey during the ’93 Spring semester we will hold a meeting 
to discuss the results of the study. The information meetings will take place on 
December 1 and December 2 at 12:00 noon and 6:00 p.m. in PhP 328. The meetings 
are open to those who did not participate but who have an interest in the topic.
If you are unable to attend at any of these times, you may contact the principal 
investigator, David Brown, at 1-777-3555. Thank you for your valuable help.
David E. Brown
Clinical Psychology Graduate Student
